ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000363.1|Glycopeptidolipid_1 # 3 # 2384 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.618	BGC0000363.1|Glycopeptidolipid_1 	3	2384	+	Loose	1900	30.0314	MexI	28.43	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ACTCCGGGGCTGCCGCCGGGGGTCAAGACCTATGTCACGGGTCCCGCCGCCGTCGTCTCCGATATGTCGGAGAGCGGAAACCGGACGGTCATCCTCATCACCTTGGTGAGTGTTGGCGTGATTTTCCTGATGCTGCTCCTGCTCTACCGGTCATTCATCACGGTCATCATCTTGCTGTTCACCGTCGGCATCGAGCTGCAGGTTGCGCGAGGACTGGTCGCGTTCCTCGGTATGCACGGGATCGTGGGTCTTACCACCTTCGTGGTCAACCTGCTGGTGTCTGTGGGCATCGCCGCAGGTACGGACTATGGAATCTTCTTCACCGGGCGTTATCAGGAGGCGCGTCAGGCGGGCGAGGATCGCCAGACCGCCTACTACACCGCCTACCGCGGAGTGGCCAAGGTTGTGCTGGCATCCGGCCTGACCATCGCCGGTGCGATCGCGTGTCTGCATTTCACCCGGCTGCCGTACTTCAAGCCGCTGGGTATCCCGGGCGCGGTCGGAATCCTGGTCGCGGTGGCGGTTGCGCTCACCCTGGTTCCGGCGTGCATCGCCGCGGGTAGCCGCTTCGGGCTGTTCGATCCCAAGCGGCAGGTGACCACGCGCCGCTGGCGGCGGCTGGGTACCGCGATCGTGCGTTGGCCCGGACCGATCCTCGCCGGGACGGTGGCGATCTCACTCATCGGTCTTTTGACACTGCCGGGATACAACCCCAGCTACACCGACGCGAAGTACATACCCAAGGACATCCCCGCGGTCCAGGGACTCGTTGCCGCCTCACGGCACTTCCCGGAATCGAAGATGTCTACGCCCGACATTCTGTTGGTCGAGGCCAATCACGACATGCGTAACTCGGCTGATCTGCTGGTGCTGAACAGGTTGGCCAAGGCCGTCTTCGCGGTCCCCGGCATCGCCAACGTGCAGTCCATCACGCGCCCCGAGGGAACCCAGATCGAGCACTCCTCAGTGCCGTTCATGCTCAGCATGTCGAATGCGAGCCAGCGGTTGAGCCTGCCGTTCCAGCGTGCGCGCATGGACGACATGCTCAAGCAGGCCGATGACATGGGAACGACGATCGCGCTCATGCAGCGCATGTTCGACCTGATGAAACAGATGGTGGCGACGACTCACCGGATGGTCAGCACCACGCATGATCTTCAGAAAGATATGTCGACGCTGCGCGACCACATCGAGAACTTCGAAGACTTCTGGCGACCGATCCGTAACTACTTCTATTGGGAGAAGCACTGCTTCGACATTCCCATCTGCTGGTCGATCAGGTCGATCTTCGATGCGCTCGACGGCGTCGATCAGGTGACCGACAAGATGCAGACTCTGGTGGGCGACCTCGACGAGCTGGACAGGCTGATGCCGCAGCTGCTCGAGCAGTTCCCCATCATGATCGACACCATGAAGAGCACCCGCGAATCGATGCTGACGATGCACAGCACGATGTCCGGCATCTTCGCCCAGATGGATGAATCCACCGAGAACTCGACGGCCATGGGCAAGGCGTTCGACGCCTCAAAGAACGATGACTCCTTCTATCTGCCGCCGGATGTGCTGAACAACAAGGACTTCAAGCGGGTCATGAAGATCTTCATGTCGCCCGATGGCAAGTCGACGCGCATGCTCATCTCTCAGCGTGGAGATCCCGCGACACCCGAAGGCATTGCGCGGGTGGATCCGATCAAGACCGCCGCGGAGGAAGCACTCAAGGGAACTCCGCTGGAACACGCGAAGATCTCTCTGGCGGGTACGGCGGCGGGTGTCAGTGAGCTGGTCGACGGATCAAAATACGACCTCTTGATCGCAGGGGTCGCTGCCCTGTGCCTCATTTTCATCATCATGTTGTTGATGACGCGAAGCTTGGTGGCCGCGCTGGTGATCGTCGGGACCGTGGCGTTGTCGCTGGGTGCGTCATTCGGTTTGTCTGTGCTTGTCTGGCAACACATTTGCGGCATCCAGATCAACTGGGTGGTGTTGGCCATGTCGGTCATCGTGCTGCTGGCGGTGGGCTCTGACTACAACCTGCTGCTCGTCTCGCGCATGAAAGAGGAGTTGGGCGCCGGCCTCAATACGGGCATCATCCGGGCGATGGGCGGTACCGGCAAGGTGGTGACCGCTGCCGGGCTGGTCTTCGCCGCGACGATGGGCTCCATGATCGTCAGCGACCTGCTCACCCTGGGGCAGGTGGGCACCACGATCGGTTTGGGTCTGTTGTTCGACACCTTGATCGTGCGAGCGTTCATGACCCCGGCCATTGCCGCGCTCCTGGGCCGGTGGTTCTGGTGGCCACTGCAGGTGTCGCCCCGGCCGGTCGGTGCGGTGCACGGGTGGAAGGGACCGCGCCTCGTCCGTTCCGTGCTGCAGAGGAACTAG	TPGLPPGVKTYVTGPAAVVSDMSESGNRTVILITLVSVGVIFLMLLLLYRSFITVIILLFTVGIELQVARGLVAFLGMHGIVGLTTFVVNLLVSVGIAAGTDYGIFFTGRYQEARQAGEDRQTAYYTAYRGVAKVVLASGLTIAGAIACLHFTRLPYFKPLGIPGAVGILVAVAVALTLVPACIAAGSRFGLFDPKRQVTTRRWRRLGTAIVRWPGPILAGTVAISLIGLLTLPGYNPSYTDAKYIPKDIPAVQGLVAASRHFPESKMSTPDILLVEANHDMRNSADLLVLNRLAKAVFAVPGIANVQSITRPEGTQIEHSSVPFMLSMSNASQRLSLPFQRARMDDMLKQADDMGTTIALMQRMFDLMKQMVATTHRMVSTTHDLQKDMSTLRDHIENFEDFWRPIRNYFYWEKHCFDIPICWSIRSIFDALDGVDQVTDKMQTLVGDLDELDRLMPQLLEQFPIMIDTMKSTRESMLTMHSTMSGIFAQMDESTENSTAMGKAFDASKNDDSFYLPPDVLNNKDFKRVMKIFMSPDGKSTRMLISQRGDPATPEGIARVDPIKTAAEEALKGTPLEHAKISLAGTAAGVSELVDGSKYDLLIAGVAALCLIFIIMLLMTRSLVAALVIVGTVALSLGASFGLSVLVWQHICGIQINWVVLAMSVIVLLAVGSDYNLLLVSRMKEELGAGLNTGIIRAMGGTGKVVTAAGLVFAATMGSMIVSDLLTLGQVGTTIGLGLLFDTLIVRAFMTPAIAALLGRWFWWPLQVSPRPVGAVHGWKGPRLVRSVLQRN	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	77.07	gnl|BL_ORD_ID|4683|hsp_num:0	1647			825	1350	acriflavine; tetracycline; norfloxacin
BGC0000363.1|Glycopeptidolipid_2 # 2394 # 5327 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=TAG;rbs_spacer=9bp;gc_cont=0.608	BGC0000363.1|Glycopeptidolipid_2 	2394	5327	+	Loose	2070	40.0466	smeE	24.74	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTACCGAGCAGTCGCGCCCGTTCATCGCGCGAACCATACGAAACCTGTCGCCCCTGATCATCCTGGGCTGGCTGGCGCTAATTCTGTATACGACGCTGGCATCGGTCAATTGGGACTTGACCAAGGCGATTCCGGCATTGGAGAACGTTGCAGAAGAGCGGTCGGTATCGCTGATGCCGCAGGATGCGCCGGCCGTCAAGGCCATCATGCGCATGGGCAAGGACTTCAACGAATCGAACTCTGACAGCTCCGCGATGATCGTGCTCGAGGGGAAGGACCCGCTCGGCGAGGACGCGCACACGTACTACGCCGGACTGATCCGCGAGCTGCGGAACGATCCCAAACACGTAGAGCACGTGCAGGATCTGTGGGGCGATCGGCTGACATCCTCGAGTGTGCAGAGTCCCGATGAAAAGGCTGCATACGTGCAGCTGAATCTCGTCGGCAATCAGGGCACCGCGATGGGTGACGAATCAGTGGCCGCGATCCGCGAAATCGTCAATCGGACACTGCCTTCGGCGCCCACCGATGTGAAGGTCTACGTGGCCGGTGCGGCGCCGCTCGCTTCGGACATGCAGCATGCCGGCAACAAATCGATTTTGAAGATCACCGCGGTCACCGTGGTCATCATCTTCACGCTGCTGTTGATCCTCTATCGCTCTGTTGTCACCGTGATCCTGCTGCTGATCATGGTGGGTGTCGAATTGGCCGCGGCCAGAGGCATTGTGGCGTTCCTCGGCTACCACGATGTTTTTGTGTTGTCGACATTCGCCGTCAACATGCTGGTCTTCTTGAGCATCGCCGCAGGCACCGATTACGGGATCTTCTTCTTCGGTCGCTATCAAGAGGCACGCCAGGCCGGTGAGGACCGGGAAACGGCCTACTACACCACATATCGCAGTGTTGCTCCCGTCGTCCTGGCTTCCGGACTGACCATCGCCGGGGCCATTCTGTGCCTACATTTCACGCGGCTGCCCTATTTCCAGACCATGGGAATCCCCTGTGCCATCGGAATGCTGACGGCCGTCGCGGTCGCGGTCACCCTGGTACCCGCGGGGATTGCGGTGGCCAGCCGATTCGGACTGCTTGAACCCAAGCGCAAGCTGCGGGTTCAGCGGTGGCGTGGGCTGGGTACGGCCATTGTCCGCTGGCCCGCACCCATCCTGGTCGCCTCACTGGCAGTGGCACTGGTCGGGTTGTCCACGCTGCCGGGATACAAGACGAGCTACAACGACCGGCTGTACATCTCCGGGGATATCCCGGCCAATCAGGGATTCGCTGCCGCGCAACGTCACTTCTCCGAGTCGCGACTGACGCCCGATGTGTTGTTGATCGAAACCGACCGGGATCTTCGGAACCCGGCCGACTTCCTGGTGTTGAACAAGGTGGCGAAGGCCATTTTCAAGGTGCGCGGAGTCTCACGGGTACAGGGGATCACCCGGCCCGAGGGAACTCCGATCGCCAACACATCGGTGCCCTTCCTGCTCAGCTTGCAAAGCGCCGGCCAGGTGCAGGCGACCCGCTTCCAGAAGAAGCGCATCGCCGACATGCAAAAGCAGGCCGACGACATGTCGAAGATGATCGCGACGATGCAGCACACATACCTCGTGATGAAGCAGATGTCCGAGACCACGCACCGCATGACGGGCCACACCCATGAGGTGCAGCAGCTCACCGACGACTTGCGGGGCAGTATCGCGCTGTTCGATGACTTCCTTCGACCGATACGCAACTATTTCTATTGGGAGAAGCACTGTTTCGACATCCCAATCTGCTTCTCGCTTCGATCGATCTTCGATGCGTTGGACGCGGTCGACGCGCTCGATGACGGGCTGATGGTTCTGGTCAGGGACATGGATCAGCTGGACGCCATCATGCCGCAGCTGCTTGTCCAGTTCCCTCAGATGATCTCGGTCATGCAGAGCATGCGCACCTCGGTGCTCACCATGTACGCCACCATGTCCGGGCAGTTCGCTTCGATGGACGAATCCACCAATGACGTGATGGCCATGGGGCAGGCATTCGATGCCTCCAAGAACGACGACTCGTTCTTCCTGCCTCCAGAGGTGTTCAAGAACCCGGACTTCCAGCGTGCGATGAGTTCGTTCCTGTCGCCGGATGGAAAGACGGTGCGGTTCATCATCTCCCATAACGGTGATCCGATGTCGCCGGAGGGCATCACGCGGATCGAGCAGATTCGGAATGCGGCGGAAGAGGCACTCAAGGGAACGCCACTGGTGGGAGGCAAGATCTATCTGGCCGGCGCCGCATCGACGGCAAAGGACTGGAAAGACGGCTCCACGTACGACCTGCTGATCGCGGGCATCGCGGCGATCTGCCTGGTTTTCATCATCATGCTCATCACCACCCGAAGCTTCATCGCGGCCTTGGTGATCGTCGGTACGGTGGCCCTCTCCTTGGGCGCGTCCTTTGGCATGTCCGTGCTGCTGTGGCAGTACATCCTTGGCATCAATCTGCACTGGATGGTGCTGGCGATGTCCGTGATCATCCTTTTGGCGGTCGGATCCGATTACAACCTGCTGCTGGTGTCTCGTATGAAAGAGGAGCTGGGTGCGGGGCTGAACACGGGCATCATCCGGGCGATGGGCGGCACCGGAAAGGTCGTCACCTCAGCCGGATTGGTGTTCGCGGCCACTATGGCCTCGATGGTGGTCAGTGATCTGCAGATCATCGGTCAGATCGGAACCACGATCGGGCTGGGCCTGTTGTTCGACACGTTGATCGTCCGCTCGTTTATGACGCCGGCGATCGCGGCCCTCCTGGGCCGATGGTTCTGGTGGCCGCAGCGAGTGCGTCCGCGTCCGCCGAGTGCGCTGCTCGCGCCGGTGGGCGCGCGCCCGGCGGCGCCTGCCCCGGGCCGCCTCGACGATGACGAGCCGACCACGGAACTACCGAAATTCAACGACTAA	MSTEQSRPFIARTIRNLSPLIILGWLALILYTTLASVNWDLTKAIPALENVAEERSVSLMPQDAPAVKAIMRMGKDFNESNSDSSAMIVLEGKDPLGEDAHTYYAGLIRELRNDPKHVEHVQDLWGDRLTSSSVQSPDEKAAYVQLNLVGNQGTAMGDESVAAIREIVNRTLPSAPTDVKVYVAGAAPLASDMQHAGNKSILKITAVTVVIIFTLLLILYRSVVTVILLLIMVGVELAAARGIVAFLGYHDVFVLSTFAVNMLVFLSIAAGTDYGIFFFGRYQEARQAGEDRETAYYTTYRSVAPVVLASGLTIAGAILCLHFTRLPYFQTMGIPCAIGMLTAVAVAVTLVPAGIAVASRFGLLEPKRKLRVQRWRGLGTAIVRWPAPILVASLAVALVGLSTLPGYKTSYNDRLYISGDIPANQGFAAAQRHFSESRLTPDVLLIETDRDLRNPADFLVLNKVAKAIFKVRGVSRVQGITRPEGTPIANTSVPFLLSLQSAGQVQATRFQKKRIADMQKQADDMSKMIATMQHTYLVMKQMSETTHRMTGHTHEVQQLTDDLRGSIALFDDFLRPIRNYFYWEKHCFDIPICFSLRSIFDALDAVDALDDGLMVLVRDMDQLDAIMPQLLVQFPQMISVMQSMRTSVLTMYATMSGQFASMDESTNDVMAMGQAFDASKNDDSFFLPPEVFKNPDFQRAMSSFLSPDGKTVRFIISHNGDPMSPEGITRIEQIRNAAEEALKGTPLVGGKIYLAGAASTAKDWKDGSTYDLLIAGIAAICLVFIIMLITTRSFIAALVIVGTVALSLGASFGMSVLLWQYILGINLHWMVLAMSVIILLAVGSDYNLLLVSRMKEELGAGLNTGIIRAMGGTGKVVTSAGLVFAATMASMVVSDLQIIGQIGTTIGLGLLFDTLIVRSFMTPAIAALLGRWFWWPQRVRPRPPSALLAPVGARPAAPAPGRLDDDEPTTELPKFND	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	93.94	gnl|BL_ORD_ID|807|hsp_num:0	876			678	1488	tetracycline; chloramphenicol
BGC0000363.1|Glycopeptidolipid_3 # 5897 # 6763 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=TAG;rbs_spacer=8bp;gc_cont=0.622	BGC0000363.1|Glycopeptidolipid_3 	5897	6763	-	Loose	950	25.7942	fusH	30.3	3003026	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic inactivation	fusidic acid inactivation enzyme	ATGCGCGGCATCATTCTCGCGGGCGGTTCGGGCACGCGCCTGCATCCGATAACGACGGGTGTCAGCAAGCAGCTGCTACCGGTGTACGACAAACCGCTGGTCTACTACCCGCTCTCCACGCTGATCATGGCCGGGGTTCGGGACATTCTGGTGATCACCACCCCCTCGGACGCCCCGGCATTCGAGCGACTCCTCGGAGACGGCTCGGCATTCGGCATCAACCTCACCTACGCGGTCCAGCCCAAGCCCGAGGGCCTCGCGCAGGCGTTCGTGATCGGAGCCTCGCATATCGGCACCGACACGGCGATGCTCGCCCTGGGTGACAACGTCTTCTACGGGCCCGGGTTGGGCACGAGTCTGCGCCGGTTCGAGAACATCAGCGGTGGAGCCATTTTCGCGTACTGGGTGGCCAACCCGTCGGCATACGGCGTGGTGGAGTTCGACGCCGCGGGCGTCCCATTGTCCCTGGAAGAAAAGCCCGCGACGCCCAAATCCCACTATGCGGTGCCCGGTCTGTACTTCTATGACAACGACGTCATCGAGATCGCGCGCTCGCTGAAGAAGTCGGCTCGGGGTGAGTACGAGATCACCGAGGTCAACCAGACCTATCTGGACCAGGGACGTCTTTCTGTCGAAGTGCTACCGCGTGGAACCGCGTGGCTGGATACGGGCACCTTCGATTCACTGCTGGACGCGAGCGACTACGTGCGCACCATCGAACGCCGACAGGGCCTGAAGATAGGCGTACCGGAAGAAATTGCGTGGCGCGCAGGTTTCATCAATGACGACCAGCTCGCTGCGCGTGCTCAGGAGCTGCTCAAGTCTGGATACGGAAGTTACCTACTTGAGCTCTTGCAGCGGAAATAA	MRGIILAGGSGTRLHPITTGVSKQLLPVYDKPLVYYPLSTLIMAGVRDILVITTPSDAPAFERLLGDGSAFGINLTYAVQPKPEGLAQAFVIGASHIGTDTAMLALGDNVFYGPGLGTSLRRFENISGGAIFAYWVANPSAYGVVEFDAAGVPLSLEEKPATPKSHYAVPGLYFYDNDVIEIARSLKKSARGEYEITEVNQTYLDQGRLSVEVLPRGTAWLDTGTFDSLLDASDYVRTIERRQGLKIGVPEEIAWRAGFINDDQLAARAQELLKSGYGSYLLELLQRK	MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL	56.58	gnl|BL_ORD_ID|65|hsp_num:0	75			915	1077	fusidic acid
BGC0000363.1|Glycopeptidolipid_4 # 7325 # 8488 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.633	BGC0000363.1|Glycopeptidolipid_4 	7325	8488	+	Loose	600	63.929	rgt1438	31.4	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGGCGGTGCCGCCAGACTTGATCGGCTTCGCCGAGTCTGTCGGGCTCTCGGCAGTTCCCTACGGCGTCCAGGTGGGGCCCCAGCTTGATGAGTATCGCGACTTGTGGATGTCGTGGACCCGTCATTTTTGGAGGGTTCAGGATTTGGTCGCGTTGTGTCAGCAGGCACTGAAACTGGTCACCGAACAGTGGTCGGAAATGAGTAAGGCCCTTGTGTCGGTGGCCGAGGGGGCGGATCTTCTGTCGACCAGTGTGGGCTATGAGGAGCCGGCCGCCAATGTTGCCGAGTTCTACGGAATCCCACTGGTTGCCTTACACACCATGCCGTGGCGCCCCAATGGTCAGCTCTTTCCCGTCCTACCGCCGCCGGTGACCCGCACAGCGATGACCGCCTACGACTGGTTGACCTGGCGTGTGACCAAGAGGGCGGAGGATGCGCAACGGCGCGAGCTGGGATTGCCGAAGGCGACAAGCCCGTCGCCGCGTCGGATCGGGCAGCGTGGGTCGCTGGAAATCCAGGCCTACGACCGCATTTGCTTCCGCGGGCTGGCAGATGAGTGGGCGAAGTACGGCGAGCGCAGGCCTTTCGTGGGGGCGCTGACCATGGAGTTGACCACCGCGGCCGATGACGAGGTCATGTCCTGGATTGCCGCCGGTCCGCCGCCTATCTGTTTCGCTTCGGGAAGCATTCCGGTTGAATCTCCGGCGGAGACCGTCGAGATGATCGGTTCAGCATGCGCGGAATTGGGGGAGCGCGCGTTGGTATGCGCCGGCGCCACCGACTTCGGCGACGTACGGCCACCCGAGCACGTCAAGGTGGTCGGCGTGGTGAACTATGCGGCAGTCTTTCCGGTGAGTCGGGCGATTGTTCACCACGGTGGGTCGGGCACCACGGCTGCGAGCCTACGCGCCGGAGTGCCTACCTTGATCCTGTGGACCGTTGGTGATCAGCCATTCTGGGGAAATCAGCTCAAGCGCATGAAAGTGGGCGCCTCTCGGCGCTTTTCGACCACTTCCTGGGACACCTTGGTCTCAGACCTGCGGGAGATCCTCAGCCCGGACTATGCGGTTCGGGCTCGGGAGATCGCTCCGCACATGTCCAAGCCGTACGAGAGTGTCGGCAAGGCAGCCGACCTGTTGGAGGAGCGGGCTGCTCGTGTTTAG	MAVPPDLIGFAESVGLSAVPYGVQVGPQLDEYRDLWMSWTRHFWRVQDLVALCQQALKLVTEQWSEMSKALVSVAEGADLLSTSVGYEEPAANVAEFYGIPLVALHTMPWRPNGQLFPVLPPPVTRTAMTAYDWLTWRVTKRAEDAQRRELGLPKATSPSPRRIGQRGSLEIQAYDRICFRGLADEWAKYGERRPFVGALTMELTTAADDEVMSWIAAGPPPICFASGSIPVESPAETVEMIGSACAELGERALVCAGATDFGDVRPPEHVKVVGVVNYAAVFPVSRAIVHHGGSGTTAASLRAGVPTLILWTVGDQPFWGNQLKRMKVGASRRFSTTSWDTLVSDLREILSPDYAVRAREIAPHMSKPYESVGKAADLLEERAARV	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	94.16	gnl|BL_ORD_ID|116|hsp_num:0	134			702	1212	rifampin; rifaximin; rifabutin; rifapentine
BGC0000363.1|Glycopeptidolipid_5 # 8584 # 9702 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=15bp;gc_cont=0.617	BGC0000363.1|Glycopeptidolipid_5 	8584	9702	+	Loose	1200	34.2686	arnA	35.94	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGCCGGTTACCTGGCTGGTCCGTAAAGAACGGGAGGAATCGGCTTTGTCGACATCTGTACTCATCTCTGGTGGAGCGGGATTCATTGGATCCGCACTATCCAACCGCCTCGTGCAGGCGGGATACGACGTCGCGGTGATGGACGTCTTACATCCTCAGGTGCATGCCAGGGGCCGGGACATCGACCTCCCGCCATCGGTGCGGCTGTTCACGGGCGACGTGACCCATGCCCCTGACTGGGATGCCGTGCTGCGGTTGTTCGAACCCTCGCAGGTTGTCCATTTAGCTGCGGAGACGGGTACCGCGCAGTCGCTTTCGGAAGCGACGCGTCACGGCTCGGTCAATGTGGTGGGTACCACCCAACTCCTTGATGCCCTGAGCCGTGCGGCATTTGTGCCCGACCAGCTGGTACTTGCATCATCGCGCGCGGTGTATGGCGAAGGTGCCTGGCAGTCCGGTACGGAAGTCTTCTACCCGCGCCCGCGCAGCCATGCCCAGCTACTTGCCGGCCGGTGGGATCCGAAGGGTCCCACCGGTGAGTCTTCGGAGCCGCTCGCCAGCTGCGCCAGTAGGACCGAGCCCCGGCCCACCAATATCTATGCGGGCACAAAACTCGCCCAGGAACATCTGTTGGCTTCCTGGGCTGCCGCCCATGACACCAACCTCAGCGTTCTGCGTCTGCAGAATGTGTATGGGCCCGGCCAGTCACTGACAAACTCGTACACCGGAATCGTCACGCTCTTCGCGCGTCTGGCGCGCGAGAAGCAGTCCTTGGAGGTGTACGAGGATGGACGGATAGTTCGCGATTTCGTTTTTATCGACGATGTTGTCGATGCGCTCTTTGCCGCGGTACACACACCCGCAGTCGAGCGACGCACTCTCGACATCGGTTCTGGCACTGCGACAACCATTCATGAGTTGGCCCGTAAGGTCGCCGAAATCTGTGCGGCACCCGAACCCACCGTTGTCGGAAAGTTTCGGGATGGCGATGTGCGCGCCGCGAGTTGTGACGTCGAGCCGGCAATCGAGCAGCTCGCGTGGAGCCCGAAGTGGACGCTCGAGGACGGCCTGCACGCACTTCTGGAATGGATCGACAAGGACTGCCCGAATCGCTTTTGA	MPVTWLVRKEREESALSTSVLISGGAGFIGSALSNRLVQAGYDVAVMDVLHPQVHARGRDIDLPPSVRLFTGDVTHAPDWDAVLRLFEPSQVVHLAAETGTAQSLSEATRHGSVNVVGTTQLLDALSRAAFVPDQLVLASSRAVYGEGAWQSGTEVFYPRPRSHAQLLAGRWDPKGPTGESSEPLASCASRTEPRPTNIYAGTKLAQEHLLASWAAAHDTNLSVLRLQNVYGPGQSLTNSYTGIVTLFARLAREKQSLEVYEDGRIVRDFVFIDDVVDALFAAVHTPAVERRTLDIGSGTATTIHELARKVAEICAAPEPTVVGKFRDGDVRAASCDVEPAIEQLAWSPKWTLEDGLHALLEWIDKDCPNRF	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	56.19	gnl|BL_ORD_ID|1513|hsp_num:0	1643			951	1131	polymyxin B
BGC0000363.1|Glycopeptidolipid_6 # 9867 # 10994 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.602	BGC0000363.1|Glycopeptidolipid_6 	9867	10994	+	Loose	200	26.9498	vanT gene in vanC cluster	29.31	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAAGCTCGGTTCTGTATTCGATCCGCGAAACAACGCGCTGAACGCATGTCGGCTCGCCCTGGCGACAGAGGTAATCCTTTTTCACTCGTTTCCGCTTACTGGTCACGTAGTGGAATCCAAGGCGATACTTCAACTGCTGTTTTCGGTAGGAGTTGACGGATTCTTTGCTCTTTCGGGATTTCTGATCACTGCTAGTTGGCTCCGTAATCCCAGCTCGCGCGACTACTTCATCGCGCGAGCCCTGCGCATCCTGCCCGGGTACTACGTGGTACTGGCGGTAACGGCGTTTGTCATCGCTCCGCTCAGCGTTGCGATCCAGGGCGGATCGGCCGCGAGGCTGCTGTTCTCCAGTGCGCCGATCGAATACATGTTGAAGAACAGCGCGCTGATTCAGCTCCAGTTCGACGTGGGTGGGACGCCGCGCGATATCCCGTATCCGGGAATCTGGAACGCGTCCCTGTGGTCGCTCGTATTCGAAGTGATGTGCTACATCGCCGTAGCGGGGCTGGGGCTACTGGGGCTCGCCAGCCGTCGCTGGACCGCACCGGTGATACTGATATTGGCAACGATTGCGGCCATTCTCCTGCCGCCGCTGACCTTCCCGGGGCTATGGACAATTCCGCAGCTCGCGGTGCGCAGTGCCATCATGTTTTCCGCCGGTGCACTGCTGTATCAGTGGCGAGATGTGATTCCGGCCCGGTGGTCGCTTGTGTCGGTGAGCGTGGTGATTGTGCTGGCATCGGGCATGCTGCCCGACTACCGCGTCATCGGTGCTCTTCCGCTTGCCTACGCCGTCGTCGTTTCGGGTGTCCTGATCAAGAACAAGCGCATGAACATCCAGACGGACCTGTCATACGGTGTCTATATCTATGCCTCGCCGACGCAGCAGTTCTTAGCTGTCGCGGGCCTTGCCAGCCTGAATCCGTTTGTTTTCTTTGTTGTTTCGGCGGGTGCAACGCTGGTGCCCGCCGCGTTCAGTTGGTTCCTGGTCGAGAAGCGTGCCCTCGCGCTCAAGTCGCGCCTTAAACGCAAGCATGCCGATCAGGCGGCGACGCGCGCGGGGCCTGCGGGTTCGGATAGCCCCGCGCCGCGAGAACGGGCACTATCGCCGCGCGAGGACAGTTAG	MKLGSVFDPRNNALNACRLALATEVILFHSFPLTGHVVESKAILQLLFSVGVDGFFALSGFLITASWLRNPSSRDYFIARALRILPGYYVVLAVTAFVIAPLSVAIQGGSAARLLFSSAPIEYMLKNSALIQLQFDVGGTPRDIPYPGIWNASLWSLVFEVMCYIAVAGLGLLGLASRRWTAPVILILATIAAILLPPLTFPGLWTIPQLAVRSAIMFSAGALLYQWRDVIPARWSLVSVSVVIVLASGMLPDYRVIGALPLAYAVVVSGVLIKNKRMNIQTDLSYGVYIYASPTQQFLAVAGLASLNPFVFFVVSAGATLVPAAFSWFLVEKRALALKSRLKRKHADQAATRAGPAGSDSPAPRERALSPREDS	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	53.72	gnl|BL_ORD_ID|4675|hsp_num:0	734			3	177	vancomycin
BGC0000363.1|Glycopeptidolipid_7 # 11065 # 11919 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=15bp;gc_cont=0.605	BGC0000363.1|Glycopeptidolipid_7 	11065	11919	+	Loose	300	25.7942	Erm(37)	27.42	3000392	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTTTTTCGAACATCAAAGGACAGCAAAGGATCTCGTGACCATGCCGCTCTTCCGTCTGGCACTGCAGGGCAAACCTCCGTTTGTTGCGCGACGTTATCCGTACGGGTCCCGCCGTCGAATGCTCGGTGCGCTGGGTCCGGACCTGGCCAGGACGGTCTCGATGCGCGCCGACGACTCGGCACCGGCGGATACCCCCATCGGGAGAATCTTCGAGAACACCGACAACGTCCACAAGCTGCGTCATTACCTGCCCATCTACCAGCGCGCTCTCACGGGGATCGAGCGAATGCTCGAGATCGGGGTGGACCGGGGCGGATCCCTACAGATGTGGCGGGAACACCTGCCACGGGCCACCATTGTGGGTCTGGACATCAGCCCCAAGTCTGCGCAGCACGACGACCCGGGGCGTGATATCCACGTGCGGATCGGTGACCAGACCGATCCGCACTTCCTCGGGACGGTGGTCGAGGAGTTCGGCCCGTTCGACGCCGTCCTCGATGATGGTGGCCACACCCCGAAGCAGATGATCGGGTCATTCAGGTATCTGTTTCCGCGCCTGCGGCCCGGCGGTGTCTATATCGTCGAGGATGTCTGTGCGAACTACTGGACGATCTATCGTGACCAGCGTCAATCGTTCATCGATTTCACCAAATGGCTGATGGACGCGATGCATGCTCATTATATGGAGATGAGCTCGGTCTACCAGATCATGGAGGACCATCCCAAGCGGCTTGAGACAGTCGAGGTGCCGTTCGCGGCCACCATCATCGACCGGATCGAGGTGTTCGACTCCGTAGTCGTGATTCACCGCGCAGAAGAGTCGAAGCGGCTACCCCGTGCCGTGTTCCGATGA	MFFEHQRTAKDLVTMPLFRLALQGKPPFVARRYPYGSRRRMLGALGPDLARTVSMRADDSAPADTPIGRIFENTDNVHKLRHYLPIYQRALTGIERMLEIGVDRGGSLQMWREHLPRATIVGLDISPKSAQHDDPGRDIHVRIGDQTDPHFLGTVVEEFGPFDAVLDDGGHTPKQMIGSFRYLFPRLRPGGVYIVEDVCANYWTIYRDQRQSFIDFTKWLMDAMHAHYMEMSSVYQIMEDHPKRLETVEVPFAATIIDRIEVFDSVVVIHRAEESKRLPRAVFR	MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR	158.66	gnl|BL_ORD_ID|421|hsp_num:0	468			132	285	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000363.1|Glycopeptidolipid_8 # 12133 # 12939 # 1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=TAG;rbs_spacer=9bp;gc_cont=0.581	BGC0000363.1|Glycopeptidolipid_8 	12133	12939	+	Loose	500	24.6386	BPU-1	39.29	3004759	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BPU Beta-lactamase	TTGACCGTGACCGATTACGACACTCGATCCGCTTATCTGGGTCTGCTTCGGCAGGACCTCACCAGATACGGAGTTGATGAACTTGTGCCAGTGGGTTGGAACTGGCTGCACCGCCCCTTTTTCAAATTTGGCGACTACGTGCTTGTGCGCAAGCGTCCGTTCGACGCGCACAAGCGCGACTTGGGCCTGGATTGGCCGGCGGATGCGCTGACGATGATCGGTATGCAGCGACTCACCAGCTTGCAGCAGTGCGTCGAGACGGTGCTTGCCGATGACGTGCCAGGCGACCTGGTCGAATGCGGTGTATGGCGCGGTGGTGCGTCCATCCTGATGCGCGGGGTTCTGGCCGCGTACGGGGATACCACGCGGAACGTGTGGCTTTGCGATTCGTTCGAGGGCGTACCTCCGCCGGACACCGCGCATTACAAGGCGGACAAGGGCGACAGGCTGCACCTTGCGGCACCCATCCTGGCGGTAACCGAAAAGAATGTCAGGGCCAATTTCCAGCGCTATGGATTGTTGGACGATCAGGTTCGATTTGTTCCAGGCTGGTTCAAAGACACGCTGCATGATGCCCCGATTCAACAAATCGCTGTATTGCGGCTTGATGGTGACCTCTATGAATCCACAATCCAGGCGCTCGACGGGCTTTACGAACGTTTGTCTCCCGGAGGCTTTTGCATCATCGACGACTACCATGCGCTCGACTCGTGCAAACAGGCCGTCACCGATTACCGCACGAAGCACGGGATAACCGCCGAGATCAAGGAAATTGACGGAACCGGCGTGTTCTGGCGTAAGGAATGA	MTVTDYDTRSAYLGLLRQDLTRYGVDELVPVGWNWLHRPFFKFGDYVLVRKRPFDAHKRDLGLDWPADALTMIGMQRLTSLQQCVETVLADDVPGDLVECGVWRGGASILMRGVLAAYGDTTRNVWLCDSFEGVPPPDTAHYKADKGDRLHLAAPILAVTEKNVRANFQRYGLLDDQVRFVPGWFKDTLHDAPIQQIAVLRLDGDLYESTIQALDGLYERLSPGGFCIIDDYHALDSCKQAVTDYRTKHGITAEIKEIDGTGVFWRKE	MKKKYIKRLFSCIMLMAFCISQPSSTEARSIAWSVDEFFKNREGTFVIQEVKEKSPWVYNKKRAKERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNRDHTLGSGMRDSVVWYYQAMARDIGEERMNHWVKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYEETLPFDLKNMRTVKRMMVQEEEKHATLYGKTGSGSDIGWYVGFIKHEHKTYILATNIKGTGIEAKDITYRILKKYHLMEASV	102.29	gnl|BL_ORD_ID|2548|hsp_num:0	3564			474	549	
BGC0000363.1|Glycopeptidolipid_9 # 12989 # 14257 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=TAG;rbs_spacer=5bp;gc_cont=0.617	BGC0000363.1|Glycopeptidolipid_9 	12989	14257	+	Loose	600	97.4413	rgt1438	26.56	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGAAGTTTGTGCTGGCGAGCTACGGAACCCGGGGTGATATCGAGCCCTCCGTTGTCGTGGCTCGTGAGTTACAGCGCAGGGGACACGATGTGGTCATGGCTGTGCCGCCCGACCTGATCGGCTTCACGGAGTCGGCTGGTCTGGAGACTGTTTCCTACGGGTTGGATACGAAGACCTGGCTGGACGTTTATCGCAATTTCTGGACGTTCTTCTTCCACACCTTCTGGAAGGTGGGGGAGATTCGCACGATGTGGCGTCAGATGTGGGAGCTCAGCGACGAATGCTGGGCGCAGATGAACACCACGCTGATGTCCGCGGCCCAGGACGCCGATGTGTTGTTCGCGGGACAGAGTTACCAGGAGCCCGCTGCGAATGTCGCTGAATACCATGACATCCCATTGGTCACGCTTCATCACATCCCGATGCGGCCCAATGGTCAGCTTGTCACCATCCTGCCGTCCCGGTTGGGGCGTACGGCAATGACGGCGTTCGATTGGGTGGCCTGGCGTCTGAATAAGAAGGTGGAGGACACGCAGCGGCGTGAGCTCCGCTTACCGAAGGCCTCACGGCCGTCGCCTCAGCGAATCGCCGAGCGCGGCTCCCTGGAGATCCAGGGCTATGACGAGGTCTGTTTCCCCGGCCTGGCCGAAGAGTGGAAGGAATGGGATGGTTTGCGGCCGTTCGTCGGATCGCTGACCATGGCGTTGACCGCCGAGGCCGATAGCGACGTCGCCTCATGGATCGCTGCCGGGACGCCGCCAATTTTCTTCGGATTTGGCAGTATGCCGGTCGAATCCCCCACTGCCGCACTCGAAATGATCGGCTCGGCGTGTGCGGAGCTGGGAGAGCGGGCCTTGATAGGCGCGGGATGGACCGACTTCAGCGATGCGCAGCTTCCCGACCACGTGAAGGTCGTGGGAGCAGTCAACTATGCGACGGTCTTTCCGGCCTGCCGGGCGGTCGTGCATCACGGGGGTTCCGGCACAACCGCGGCAAGCCTGCGCGCCGGGGTCCCCACATTGATCTTGTCGATGGATGCCAATCAGACGCTTTGGGGTGGACAGATAAAGAAGCTGAAAGTGGGTACCACGCGGCGTTTTTCGACCACCACGCGAGAATCTCTGATTGCGGATCTGCGCCAGATTCTGGCACCGGACTACGTTGACCGGGCTCGCGAGCTCGCCAACGGAATGACCACACCGGGTGAGAGCGCGGAGGCCGCCGCTGATGCCATGGAGCAGTTCGCTCGCTCAAGGTGTTCCGCGTGA	MKFVLASYGTRGDIEPSVVVARELQRRGHDVVMAVPPDLIGFTESAGLETVSYGLDTKTWLDVYRNFWTFFFHTFWKVGEIRTMWRQMWELSDECWAQMNTTLMSAAQDADVLFAGQSYQEPAANVAEYHDIPLVTLHHIPMRPNGQLVTILPSRLGRTAMTAFDWVAWRLNKKVEDTQRRELRLPKASRPSPQRIAERGSLEIQGYDEVCFPGLAEEWKEWDGLRPFVGSLTMALTAEADSDVASWIAAGTPPIFFGFGSMPVESPTAALEMIGSACAELGERALIGAGWTDFSDAQLPDHVKVVGAVNYATVFPACRAVVHHGGSGTTAASLRAGVPTLILSMDANQTLWGGQIKKLKVGTTRRFSTTTRESLIADLRQILAPDYVDRARELANGMTTPGESAEAAADAMEQFARSRCSA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	102.68	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1185	rifampin; rifaximin; rifabutin; rifapentine
BGC0000363.1|Glycopeptidolipid_10 # 14245 # 15378 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.601	BGC0000363.1|Glycopeptidolipid_10 	14245	15378	+	Loose	175	27.335	vanT gene in vanG cluster	26.32	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGTTCCGCGTGAGTGGGCCGGAGGGGCCGAGGCCAGCGAGAAACTCGACGCTCGGCCAGGTATTCGACCCGAGAAACAATGCGCTCAACGCATGGCGGTTGATCCTGGCGGTCAGCGTCATCTTCTGGCACTCCTGGCCGCTGACCGGTCGAACGATCACCTATCGCCCATTCGAGCAACTCATCGAGCAGGTCGGCGTCGACGGCTTCTTTGCGATATCGGGCTTTCTCATCACCGCGAGTTGGCTGCGCAAACCCAAGCTTCGTGATTTCGCGATTGCCCGTGGCCTTCGCATCTTCCCGGGGCTGTGGGTGTGTCTACTGATCATCGCGTTCGTCATCGCCCCCATCAGTGTCCTCATCCAGGGCGGCTCGGTCTCGGCGTTGTTCTCGTCGCACAAGCCGGTCGAGTACGTCATCAATAATGGTCTGCTGAACGTGTACTACGCCGGTGTCGATGGCACCCCGCGCGGTGTCCCATGGCCGGGCGTATGGAACGGGTCAATCTGGACGCTTGTCTTCGAGATGATCTGCTACATCGCGGTGGCGGTGCTGGGCGTCGTCGGACTCCTGAAGCGGCGATGGGTTGTTCCCGCAGCCTTCGTGCTATTCCTTTGTGCCACGGCGTATCTCTCGTACCCGGTCTTCGCGGCGACTTCTATCGCGCAGATGGTGGCACGGTTCGCTGTCATGTTCGCGGCAGGAGCCCTGCTGAACCAGTACAAAGACGTCATTCCTGCGCGCTGGTCGCTCGTTGCGGTGAGCGTCGTGATCGTGCTGGCTTCCGGACTGTTGGAGAACTATCGGGATATCGCGGCTTTGCCGTTGGCGTATGCGGTCATCGTTTCGGGATCGCTCATTCACAATCCACGACTGAACCTGCGCAACGACCTGTCCTACGGTACGTACATCTATGCCTATCCCGTGCAACAGCTACTGGTCGTCATGGGACTGGGTAGTCTGAATCTGTTGCTGTTCTTCGCTATTGCCACTGCGGCCACCGTGCCGCTAGCGGCCTTCAGTTGGTTTGTGGTGGAAAAGCAAGCGATCTCGCTGAAGTCTCGACTGAACCGAAAACGTCCCGCAGAGGTAGACACCGCGCCAGCGGCGCCGGTGGAGCGCGATGCGGTGTGA	MFRVSGPEGPRPARNSTLGQVFDPRNNALNAWRLILAVSVIFWHSWPLTGRTITYRPFEQLIEQVGVDGFFAISGFLITASWLRKPKLRDFAIARGLRIFPGLWVCLLIIAFVIAPISVLIQGGSVSALFSSHKPVEYVINNGLLNVYYAGVDGTPRGVPWPGVWNGSIWTLVFEMICYIAVAVLGVVGLLKRRWVVPAAFVLFLCATAYLSYPVFAATSIAQMVARFAVMFAAGALLNQYKDVIPARWSLVAVSVVIVLASGLLENYRDIAALPLAYAVIVSGSLIHNPRLNLRNDLSYGTYIYAYPVQQLLVVMGLGSLNLLLFFAIATAATVPLAAFSWFVVEKQAISLKSRLNRKRPAEVDTAPAAPVERDAV	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	52.95	gnl|BL_ORD_ID|1522|hsp_num:0	1561			21	192	vancomycin
BGC0000363.1|Glycopeptidolipid_12 # 16285 # 17544 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.643	BGC0000363.1|Glycopeptidolipid_12 	16285	17544	-	Loose	600	84.7297	rgt1438	28.86	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGAAGTTTGCGCTGGCGTGCTACGGCACTCGCGGCGACGTCGAGCCCTCCGTCAGCGTCGGATGCGAGCTGACCCGCAGAGGACACGACGTCTGCGTGGCAGTTCCCCCCGACCTCGTTACCTTCGCGGAGTCGGCTGGACTGGCCGCGGTTCCCTACGGCCCGGAACTACAGGATTTCCTACAGGACGAGTTCCTCCGGAATTTCTGGACTCAGTTGGTACGCAACCCCGTCGGTACGCTGCGTGAGCTGTGGGCGCCTATTGCCCGATACTGGAGCGACACCAGCGCGACGCTCGCCGCGGTGACAGACGGAGCTGATCTGTTGTCGACGGGACTCAACTTCGAGCAATCGGCCGCCAACGTGGCCGAGTATTTCGGCATCCCCCTGATGATGCTGCACCACTTCCCGATGCGTCCCAACGGTCAACTGCTTCCGATGCTTCCGGCACCGCTCGTACGATCGGGCGGCATGCTCTCCGAATGGCTGCTGTGGCGCGCCACGAAGAACGCCGAGGACACGCAGCGACGCGAGCTCGGCTTACCCAGGGCCACCGGCCCCTCGCCACGCCGGATCGCCCGCAGCGCAGCCATCGAAATACAAGCCTATGACGCGGTCTCTGTTCCCGGGCTGGCCAATGAGTGGGCGAAATGGAATGGCAAGCGGCCTTTCGTCGGAGCCCTCACGATGGGGTTATCTACCGCGGCCGACCATGAGGTGGCATCCTGGATCGCCGCGGGGAAACCGCCGATCTGCTTCGCCACCGGCAGCATTCCGCTCGAATCACCGGCCGACACCATCGAGATGATCGGTTCTGCATGTGCGGAACTGGGTGAGCGGGCGCTGGTCTGCGCTGGCGGTACCAATTTCGGTGACATCCTCCAGCCCGACCATGTCAAGGTCGTGGGCGCCGTCAACTACTCTGCCGTCTTCGCCGCCAGCCGAGCTGTTGTTCATCACGGAGGTTCGGGCACCACGGCCGCCAGCCTGCGAGCCGGCACCCCGACCCTGATTCTGTGGAGCACAGCCGATCAGCCGTACTGGGGAAACCAGCTCGGCAGGCTGAAAGTCGGTGCTGCTCGCCGGTTCTCGGCGACCAATCGAAAAACACTGGTGGCTGATCTGCGTCGTATCCTGGCGCCCGAGTACGCGGCAGCCGCCCGCGAGTTGGCCACGCGAATGACAAGCCCTGAGGATAGCGTCTCCAAGGCCGCAGATCTCTTCGAGGCCGCCGCCCGCGGTAAGGCAAGTAAGAAATGA	MKFALACYGTRGDVEPSVSVGCELTRRGHDVCVAVPPDLVTFAESAGLAAVPYGPELQDFLQDEFLRNFWTQLVRNPVGTLRELWAPIARYWSDTSATLAAVTDGADLLSTGLNFEQSAANVAEYFGIPLMMLHHFPMRPNGQLLPMLPAPLVRSGGMLSEWLLWRATKNAEDTQRRELGLPRATGPSPRRIARSAAIEIQAYDAVSVPGLANEWAKWNGKRPFVGALTMGLSTAADHEVASWIAAGKPPICFATGSIPLESPADTIEMIGSACAELGERALVCAGGTNFGDILQPDHVKVVGAVNYSAVFAASRAVVHHGGSGTTAASLRAGTPTLILWSTADQPYWGNQLGRLKVGAARRFSATNRKTLVADLRRILAPEYAAAARELATRMTSPEDSVSKAADLFEAAARGKASKK	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	101.95	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1194	rifampin; rifaximin; rifabutin; rifapentine
BGC0000363.1|Glycopeptidolipid_13 # 17683 # 18504 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.602	BGC0000363.1|Glycopeptidolipid_13 	17683	18504	+	Loose	550	38.1206	RlmA(II)	24.73	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGTGCGCAGTCATCCGGTTCGGAAGTCGCGAGATTGGGTCATCTTCAAGCTGAACGCTCAGTTCACTCAGGCGGTGCAGAAGTTCATCTACCGGCATGCCACCCGTAAGCTCGAAACAGAGAACGTCGTGTTCCTCAATTACGGCTACGAAGAGGATCCGGCGATGGATGTCCCGTTGTCGGCGTCCGATGAGCCCGATCGGTATTCCATCCAGCTCTACCACAGCACCGCTACCCAGACCGAGCTCGACGGTAGGCGGGTGCTGGAGGTCGGTTGTGGCCACGGCGGCGGAGCTTCCTACCTCGTACGCACATTGCATCCGACGTCCTATACGGGACTGGATCTCAATCCAGACGGGATCGAGTTCTGTCGCAAACGGCACAATCTTCCGGGCCTGGAGTTCACGCACGGAGATGCGCAGAACCTGCCATTTACCGATCAGTCCTTCGATGCGGTGATCAATATCGAGTCGTCGCATCTATATCCCCAATTTCCGGTGTTTCTCGCCGAGGTGGCGCGTGTGCTCCGCCCGGGCGGACATTTTCTTTACGCAGACGCGCGCAGTGCTCAGGATGTCGCTGGGTGGAAGGTGGCACTCGCGAACGCGCCGCTACGGATGGTGTCCGAGCGGGGGATCAATGTCGAGGTCCGGCGCGGGATGGAGAAGAACTTGGAGCGCTGGCGGTACGTGATCGATCGCGCCACGCCCAGACTCTTGCGCGGGATGGTTCGCAGGTTTGCGCCGGCCCAGCGTGCCTACGAGGACCTACGGAGCGGGGGAGCTGTGGAGTATCGGATGTACAGCTTCACCAAGGCATAG	MVRSHPVRKSRDWVIFKLNAQFTQAVQKFIYRHATRKLETENVVFLNYGYEEDPAMDVPLSASDEPDRYSIQLYHSTATQTELDGRRVLEVGCGHGGGASYLVRTLHPTSYTGLDLNPDGIEFCRKRHNLPGLEFTHGDAQNLPFTDQSFDAVINIESSHLYPQFPVFLAEVARVLRPGGHFLYADARSAQDVAGWKVALANAPLRMVSERGINVEVRRGMEKNLERWRYVIDRATPRLLRGMVRRFAPAQRAYEDLRSGGAVEYRMYSFTKA	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	96.81	gnl|BL_ORD_ID|2052|hsp_num:0	2274			294	552	tylosin; mycinamicin
BGC0000363.1|Glycopeptidolipid_14 # 18566 # 18811 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=TAG;rbs_spacer=7bp;gc_cont=0.663	BGC0000363.1|Glycopeptidolipid_14 	18566	18811	+	Loose	2000	23.483	Staphylococcus aureus mupB conferring resistance to mupirocin	37.5	3000510	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGAACGTCGTCGAGTCGATAGAGCGCGGTCTGGACTGGCTCGCGACGCCCAGGCAGTTACCCGGGCGCCTGGAGATGGAGACTCGGCGGGGGAAGCGCCTGGAGCTGGAGGTCGTTTCCGTCGCGATCCGGCTGCCGATCCTCAACGGTGCCGTTGTGCGGCTACCGGTGTTCGTCATGCTGATGCCGGCCGGATCCTCGCCCATCGAGGGAACGCAAGCCCGTCCCGAGCACCTTGACGACTGA	MNVVESIERGLDWLATPRQLPGRLEMETRRGKRLELEVVSVAIRLPILNGAVVRLPVFVMLMPAGSSPIEGTQARPEHLDD	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	7.84	gnl|BL_ORD_ID|4698|hsp_num:0	2271			615	687	mupirocin
BGC0000363.1|Glycopeptidolipid_15 # 18813 # 19040 # -1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.583	BGC0000363.1|Glycopeptidolipid_15 	18813	19040	-	Loose	400	22.3274	CRP	53.85	3000518	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGTTATGCGCGCACCTCCAGAAATATCCTGTGGCCGCAAAGATCATCCATACCCGCACCGATTACACCGAGCACAGCATCCTCACAGCGTTCCTCGTCGCACATCGTCAAAAGTGTGCGGAAGCGGCCCGTGAGACCGCTTTGACCAACGATGAGAGCGCCCGCGAAGGCGATATTTTCATGCGGACCGTGAAGGCCCGGCCCATGGTGGGCCTGCTACCGAAATAG	MLCAHLQKYPVAAKIIHTRTDYTEHSILTAFLVAHRQKCAEAARETALTNDESAREGDIFMRTVKARPMVGLLPK	MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	35.71	gnl|BL_ORD_ID|803|hsp_num:0	869			57	96	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000363.1|Glycopeptidolipid_16 # 19648 # 19977 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.555	BGC0000363.1|Glycopeptidolipid_16 	19648	19977	+	Loose	890	23.483	smeF	35.85	3003057	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTCAAAGTTGCGAAGATTAGAACTTTGTGAAACCCGCTACGCCGCTATAAATTCAGCCGTATGTTTGCGATGTCCACCGAAGCAACCTGGAGAAAGCGTGAGCATCAATCCATTCGATGATGACAAGGGAAGCTTTTTCGTCTTGGTCAACGACGAGGAGCAGCACAGCCTATGGCCGGCTTTCGCTGACGTGCCTGATGGCTGGCGGGTTGTATTCGGTGAAGCGGACCGTGCCGCCTGCCTGGAGTACATCGAACAAAACTGGACCGATATCCGGCCGAAGAGCCTGCGCGAGAGATTGGCGCAGGGTGGGGGTCTTGGGCGCTGA	MSKLRRLELCETRYAAINSAVCLRCPPKQPGESVSINPFDDDKGSFFVLVNDEEQHSLWPAFADVPDGWRVVFGEADRAACLEYIEQNWTDIRPKSLRERLAQGGGLGR	MEVIPMKSASLFLSIAATLALAGCSTLAPKNTAVAPAIPAQWPAEAAQGEVADVAAVGWRDFFTDARLQQVIEQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMDRRGTDAGVTEQFSAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYGADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQDRNALALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANANIGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIANADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGLDSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHERG	23.39	gnl|BL_ORD_ID|577|hsp_num:0	634			123	282	tetracycline; chloramphenicol
BGC0000363.1|Glycopeptidolipid_17 # 20334 # 30377 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.645	BGC0000363.1|Glycopeptidolipid_17 	20334	30377	+	Loose	1000	176.022	almE	30.53	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCCTTTGACCGACCAACTGCTGAAATTCGCGTTGATCCGAACGGCGGACGATCAGTACTACATGTTCGGGCTGTGCCATCACATCAACCTGGACGGCTTGGGCATGGCGATCGTGAGTCGCCGAATCGCATCGATCTACTCCGCACTGGTCGCGGGGGATCCGGTTCCCGACGCCTACTTCGGCACCCTGCAGGATCTGGTCGATCTGGAGGCGGAGTACGAAGCCTCCACCGACTACACAGAGGATCGGGAGTACTGGAGCCGTAACCTTCCGCCGGACAGCGGCCTCGATCCCCGCCCGCCGCATGCTCATGAGGGCCATGAGGGCTACACACCGACAGCGTCGGTTCAGATCGATGACACCGTAGTCGGCGAAATCAAAGACTTGACAAAGGCTTTGCGTGTTCGCCGGTACTCGGTTATCACAGCGGCCTGTGCGTTGTTGGTCCGCGGATGGTCCACGAGCGGGTCGGAAGTGGCGCTGGACTTCCCGGTCAGCCGCCGTGTTCGTCCCGAGTCGAAGACGCTTCCGGGCATGCTGGCCGGCGTGGTGCCGCTGGTACTCAGTGCCCCGCCGGAGTCCACGGTCGCCGAATTCTGCCAGCACGTTGATGTGCGCATTCGCGAACTGCTCAAGCATCAACGATTCCCGGCACATGTTCTGGACGGCGGCGAATTCGGTCTCCGGGGCCCCCGGCAGGCGGGAAACCGCGTCGCCATCAACTTCATCCCCATGAGACTCACGTTGGACCTCGCCGGTGTGCCCGCCACGGCGACGTACACCAACCACGGCCCCATGGGGCACTTCGGACTCTTCTTTATCGGAGCCAGTGACCAACTGCTCCTGAGCACCTCGGGCGACGGACTGCCGTTCTCGAAATTCGGAGTGCCGAATCTCACGGAGCGGTTGCAGCGGCTCTTATCGGAGATGGCGGCCGACCCTGATCGGCGGCTCTCCTCGCTGAATTCCCTGGTCAACGACGAGCTCACGAGCTTGGCTGAGGTTGGTAACCGTGCGGTTCTCGCGGGACCGGTTGCCTCGCGTGTATCGATTCCCGAACTGTTCTTCTCTCAGGTGGCCGCCGATCCCGAGGCCCCGGCGCTGACCTTCGGTGAGCGCACTCTGACGTACCGTGAGCTGGACGAGGCCGCCAATGCGCTGTCGGGTCAGCTTGTATCGCAAGGCGTGGGTCCCGGCGACCGTGTGGTCCTGCTGTCGGACCGCTCTGCTCAGGCGGTCATCGGCATACTCGCCGTATTGAAGGCCGGGGCGGCATATCTGCCTATCGACCCCGCGGTACCGGCGTCGCGGCTCGAGTTCATCGTCGGAGATGCGGCGCCGGCCGCGGCGATCACCACAGCCGGACTCCGGGCGCGACTGGACGGTTTCGATCTGCCGATCATCGACCTCGACGCCTCCGCTGCCGGAACGGAGCCCACGGCTCCCGCGTCTGGTGCTCGACCAGATGACATCGCGTACATCATCTACACCTCGGGAACCACGGGAGCGCCCAAAGGCGTGGCCGTCACCCATCACAACGTCACCCAGCTGATGTCGTCGCTGGATGCCGGCCTACCAAACCCTGGCGTATGGCCGCTGTGCCATTCTCTGGCATTCGACGTTTCGGTATGGGAGATCTGGGGCCCGCTGCTGCGCGGTGGCCGGCTCGTGGTCGTCCCCGAATCGATCACGGGCTCACCGGCGGAATTCCACGACGTGCTGGTCGCCGAACAGGTCACCGTACTTACGCAGACTCCGTCGGCTGTGGCCATGCTTTCCCCGGAGGGCCTGGAGTCCACGGCGCTCGCGGTGGTCGGGGAGGCGTGCCCGGCCTCGGTCGTCGAGCGGTGGGCTCCCGGGCGGGTGATGATCAACGCGTACGGTCCGACCGAGACCACGATGTGTGTGGCGATCAGCGCGCCGCTGGTGGCAGGGGCGCCGGACTCCGCCGTTCCCATTGGCGCGCCGGTACCCGGCGCGGCGCTCTTCGTATTGGACACCTGGATGCAACCGGTGCCTGCCGGCGTCGTCGGAGAACTGTATGTGGCCGGTGAAGGTGTCGCCTGCGGATACATCGGTCGCTCCGACCTGACGGCCTCCCGATTTGTGGCCTGCCCCTTCGGGCAGCCCGGTACCCGCATGTATCGCACCGGGGACCTGGTCTCGTGGGGAGACGACGGACAACTGCAGTATCTGGGCCGGGCGGATGAGCAGGTCAAGATTCGCGGATACCGTATTGAACTCGGTGAAGTTCAAGCGGCGTTGAGCGCACTCGACGGAGTGGACCATGCCGCCGCGATCGTCCGTGAGGACCGGCCCGGGGACAAACGTCTCGTTGGCTATGTCACCGGGACCGTCGACCCTGCCGAAGTGCGTAGCACCTTGGCCAAACGCCTTCCGCCCTACATGGTTCCCGCCGCGGTGGTGGTGCTTGAGGCATTGCCGTTGACGTCCAACAACAAATTGGACACCCGCGCATTGCCGACTCCCGAATATGGCGGACTGGGGGCCGACTACCGCGCCCCCGGCACCGCCGTCGAGGAAATTCTGGTCGGCGTCTACGCCCAGGTGCTCGGTGTCGATCGTGTCGGCGTTGATGACTCGTTCTTCGATCTGGGCGGTGACAGCATCCTCTCGATGCAGGTGGTCGCGCGCGCCCGGGCGGCGGGTGTGCTGTGCCGGCCGCGCGATGTGTTCATCGAACAGACGGTGTCGCGGCTGGCCGCCGTCGTCGAAATCTCCGGTGGCGAAGCCGATGTGGTGGACGAGGGACTAGGTCCCGTAGAAGTCACGCCGATCATGCATTGGCTGCGCGGCGCGCAGGATTCGGCGGGCGCGATCGACGAGTTCAACCAGACACTTGTGGTTCAGGCACCCGCGGCCGTGTCCGAGGACGACGTGGTTGTGGTGTTGCAGGCATTGCTGGATCGCCACCCCACCCTGCGGCTGCGTGCCACGGACAACGCTGGTGAATGGTCGCTGCTTGTCCCGGAGGTGGGGGCGATAGACGCCCGCGACTGCCTACGTGTCATCGACGCGTTATCGGGTGAAACGTTGGTGGCGGCACGTTCTCGACTGAACCCGGCCACCGGAGCGATGCTCAGCGCGGCGTGGGTTCCCGACACCAAGCAGCTGGTGCTGGTGATTCACCACCTGGCCATCGACGGTGTTTCATGGCGAATTCTGTTGGAAGACTTGAATATCGCGTGGGCGCAGCACCACAGTGGAGCCGATGTGGTGCTGCCGGTCGGTGGAACATCGTTTGCCCGCTGGTCTTCACTGCTCTCCGAACACGCGCGGTCCACGGAAGTGGTGGCGCAGGCCGATGCGTGGAAGGAGGTGCTGACCGCACCCGCACACGTGCCCGCGGTTCAGCCAACTACCGACACGTACGCCAACGCCGGACGTCTGTCCTTGTCATTGGATGCCGAGACCACTCGGCATCTGCTGGGTGAGGTGCCCGCGGCGTTTCATGCTGGGGTGCAAGACATTCTGCTCATCGCCTTCGGGCTGGCCTGGAACGAGTTCCTGGGCGCCGGGGGCGCGCCGATCGCGTTCGACATCGAGGGGCACGGGCGTCAGGAAGAAATCGGTGAAGCCGTGCACCGCCGCATCGACCTGTCGCGCACCGTCGGCTGGTTCACCACCAAATACCCGGCGTCATTGGCGGTAGGGGAGCTGTCGTGGGCGCAGGTGACAGCGGGCGAGTCGGCCCTCAGTCACGTGATCAAGGCGGCCAAGGAGCAGTTGCGCGCGCTGCCGGATGGGCTGACCTATGGTTTGCTGCGTTACCTGAACACCGACATCGGGCTGGACGGGTCGGAGCCGACAATCGGGTTCAACTATCTCGGGCGTCTGGGTGCGGGAGCGGCCGAGCTCTCCGAGGACTTCTGGCGGATAGACCACGAGAGCCTATCGCTGACCGATGTGGCTGCGGCCATCTCGATGCCATTGGCCCACTCGGTGGAGCTCAACGCGGGGATTGTCGAGACAAATTCGGACGCCGAGTCCGGACCCGAGCTTCGGGCCAATTGGACTTGGGCGCCTTCGGCTTTGGATGATGCACAGGCCGCGCGTCTCAGTAGGTTGTGGTTCGAGGCTCTCAGCGGGATCTGCGCTCATGTGCGTTCCGGCGGAGGCGGCCTGACCCCGTCTGATCTGGCGCCTGCGCGCCTGACTCAGCAGCAGATTGACGCGTTGGTGCAGCAGTATGAAGTCACCGACGTGCTGCCGCTTACCCCGCTGCAACAAGGACTGCTGTTCCAGGCGGGATTTGCTGAAGCCACCGGAGATTCCGCCGAGGACGACGTCTACTCGGTGCAGTTGGGTCTCACGGTCACCGGTCCCCTGAACGCGAGCCGCTTGCGTGATGCGGTGTACGCGGTGGTGAAACGCCACCCGAATCTGGCCGCCCGCTTCAGCGAGGAGTATGGGGAGCCGGTACAGATCATCCCCGCGGAGCCTGTGATCGCTTGGCAGCATGCCGAATTGGTTGGCGATGTGGATCAGCAAGTCGAGCAGCTGTGTGCGGCCGAACGTGCGGCGGTCTGCCAGATTTTCACCGAGCCGGTCTTTCGGGCGACGCTCATCTCCGGGCTCGGTGGCCCCGCGGAAAGCAGGCATCGGCTGGTGCTGACCGCTCACCACATCGTGATCGATGGCTGGTCGCTGCCGATCCTGCTGCAGGAGATATTCGGTGCCTACTACGGGCAGCGTCTACCGTCGCCTGCGCCGTACCGAAACTTCGTCACTTGGTTGGCAGCACAGGATCGCGTTGCTGCGCAACGAGCATGGGGCGTGGCACTCGACGGTTTCGAAACCCCGACGCTGGTTGGTTCGCTCGCCTCATCAGGTCGCAGGGGCTCGGAGTCGTATCGGTTGTCGGAGCAGATATCCCGCGCACTGTCCGAGTTGGCGCGTGCGCAGCGCACCACCGTGAACACGGTGCTGCAGGCCGCGTGGGCTCAGGTGCTGACCTGGTTGACCGGGCAGCACGACGTCGCATTCGGCACTGCGGTGTCCGGCAGGCCCAGCGACCTCGTCGGTGCCGAATCGATGGTCGGATTGTTGATCAACACGGTGCCGGTGCGTGCAAACATCAACGCGGCCACCACCGTTGCAGATCTACTGGACCAGTTGCAACGTGCCCACAACGACACCGTCGAGCACGAGCACCTGGCGCTCAACGAGATTCACCATGCGGTCGGCCTCGACAGGCTCTTCGACACGCTGTTCGTGTACGAGAATTACCCGATCGACGTCGGCGCGCAGCTGGGCGTGCAGGAGTTGGCCATCACCGACTTCAGTAGCCGCGAATACAACCATTATCCGTTGTCGGTTGTGGCCATGCCGGGCCATGAGCTGGGCTTGCGGGTCGAATTCGATACCGATGTATTCGAATTGGCGGCGATCGAGATCATCGTTGACAGGTTCCGTCAGGTACTGACGGCCATGATCGCGGACCCGGCCACCCGGTTGTCTTCGATCGACCTGCTCGACGCCGGTGAGCATGACCGGTTGGATACGTGGGGTAACCGCGCGGTGTTGACCCGCCCGGAACTGGCATTGACGTCGATCCCGGAACTCTTTGCCGCACAGGTGATGCGGGCACCGGAAGCAATCGCGATCACCTGTGGTGAACGTTCCTGGAGCTATGGCGAATTGGACGCGACCGCCAACAGGCTGGCGAATCATCTGGTCAGCCGTGGCGCCGGCCCGGGTGAGCGGGTGGCACTGTTGCTCCCTCGTACCGGAGAGGCGATCGCGGCGATCTTGGCCGTACTGAAGACCGGGGCGGCATATCTACCGATCGATCCCGCACATCCGGATTCCCGGGTCGAATTCGTACTGGGCGATGCGGCGCCGATCGCCGCGGTCACGACGGCGGACCTGCTGCCGCGTCTAGGCGCGTCCGGGATACCTGCCGTCGATATCAACGATCCCGCCGTGGATCGACAGTCGGACGTGGCATTGCCCGTTCCCGCTGTCGACGACATCGCGTACATCATCTACACCTCGGGAACCACCGGAGCACCCAAGGGCGTGGCGGTTACCCATCGCAACGTCGCACAGCTGTTGGAATCGCTTGACGCAGAACTGGATCTGGGTCAGGTCTGGACGCAATGCCACTCCCTGGCCTTCGACTACTCGGTATGGGAAATCTGGGGCGCGCTGCTGTACGGGGGCCGGCTGCTCATCGTGCCCGACGCGGTTGTCCGTTCCCCAGAAGATCTGCACGCCATGCTTGTCAGTGAACAAGTCAGCGTCCTGAGTCAAACTCCTTCGGCCTTCTACGCGTTGCAGACCGCCGATGCGATGCAACCCGAGGTGGGACAGCAGCTCAAGCTGCAGACGGTGGTCTTCGGCGGCGAGGCACTTGAACCGCAGCGTCTTTCACCCTGGTTTGACAGTCATCCGGGGCTTCCGCGGATGATCAACATGTACGGCATCACCGAGACGACGGTGCACGCATCGTTCCGCGAGATCGGGAGCGGAGACGTCGATAGCACCAGCAGCCCGATCGGCGTGCCGCTGGAGCATCTGGCCTTCTTCGTGCTGGATGGCTGGCTCCGGCAGGTACCGGTGGGCGTGGTCGGTGAGCTGTACGTGGCAGGGTCCGGCCAGGCGAGTGGATACCTGGGGCGTTCGGACCTGACGACAACACGTTTCGTCGCATGCCCGTTCGGGGCGCCCGGCTCGCGGATGTACCGCACCGGCGACCTGGTGCAGTGGGGCGAAGACGGTCAGCTGCGGTATGTGGGACGCGCCGACAAGCAGGTGAAGATCCGTGGGTACCGCATCGAACTGGGTGAGGTACACGCGGCACTGGCCCGTGTGGAAGGCGTAGATCAGGCAGCGGTGATCGCGCGCGAGGACCGCCCTGGCGATAAGCGGCTGGTGGGTTACATCACCGAATCAACCAAGGGGACCCTGGATCCCGCTGCGGTGCGCGCGGTGCTGGCCGAGCGACTGCCCGCCTACATGGTTCCGGCGGCCGTCGTGGTCCTGGGCGCCATGCCGTTGACAGTCAACGGCAAGCTCGACACTCGGGCGCTACCGGCGCCGGAGTATCAGGACGCCGACCACTATCGGGCTCCCGAGGATGCTGTCGAGGAGATCCTGGCCGGCATCTATGCGCAAGTGCTCGGTGTCGAACAGATCGGCGTCGACGATTCATTCTTCGACCTTGGCGGAGACAGCATTTCGTCGATGCAGGTGGTTGCCCGTGCGCGCGCCGCCGGTCTGCTGCTGCGGCCGCGTGACATCTTCGTCGAGCAGACCGTATCGCGGCTGGCTCAGGTCGCAGTGTTCGCCGATGGCGAGACGGCTGTTGTCGACGCGGGCACAGGTCCGGTCGTGGCCACGCCGATCATCCGCTGGCTGCATGGGCTCGGCGGCAAGGTCGACGAGTTCAACCAGACCGTGGTGCTGCAGGCCCCCGAAGGAGTGGCCGACGACGACGTGGTCACCGTGCTGCAAGCCCTGTTGGATCGACACGCCACCTTGAGGCTTCGCGCCGAAGACAGCGATGGCGAATGGTCGCTCCTGGTTCCGGAGACAGGGACGGTAGACGCACGCGAGTGCCTGCTCGCCGTGGACGTTCTTACCGACGAGGCGCTGCGTCAGGCGCGGTCGCGGCTGAACCCTGCCAGCGGTTCGATGCTGAGTGCACTGTGGGAGCGCGGCAGCAGTCGGCTGGTCCTCATCGTTCACCACCTGGCGGTGGATGCGGTGTCATGGCGCATCTTGTTGGAAGACCTCAACATTGGTTGGGCACAGCATCACGGCGGACAGCCGGTGGAACTGCCGCCGGGAGGAACATCATTTGCCCGGTGGGCGACACTGCTCGACCAGCACGCACGCGCCGCCGACGTGGTGGCGTTGGCCGACGCCTGGCGCCAGGTAGAGGCGATTCCGGCCGCGTTGCCGGCGGCGCATCCCACGATGGATACCTATGCCAGCGCGGGACAGTTGTCGGTATCGCTGGACGCCGATCTCACCAGGGAACTGCTGGGAGAGGTGCCCGCGGCGTACCACGCCGGGGTCCAGGACATCCTGTTGATCGCTTTCGCCCTGGCATGGAACGAGTTCCTCGGCTCGAACGGAGCCCCGATCGGCATCGACGTCGAGGGCCACGGTCGGCAGGAAGAGTTCGCAGGCGATGCGGATCTGTCCCGCACCGTCGGCTGGTTCACCAGTAAGTACCCGGTCTCGTTGGCAGTGGGTGAGCTGTCCTGGGCACACGTGGTGGCCGGTAACTCGGCACTGGCCCCAATCATCAAGGACGCCAAGGAACAACTGCGTGCGTTGCCCGACGGACTGACCTACGGACTCTTGCGGTATCTGAACCCCGACGCCGGTGTCGGGGGACCGGACCCGGCTATCGGGTTCAACTACCTGGGCCGCCTTGGCGCCGGTGGTGCGGATCTCTCCGAGGACCTCTGGCGGATAGACCCGGATGGGGTGTCGATCACGGCTGCGGCGACGTCCGTCCCGACTCCGTTGGGGCACACCGTCGAACTCAATGCCGGCGTGATGGAAGGTGCTGGGCCCGACTCGGGTCGCCTGCACGCGACGTGGACGTGGGCGCTTTCGGCGTTGAGTCACGACCAGGTTGACCGGATCAGCCGGCTCTGGTTCGACGCGTTGGCCGGGATCTGCTCGCATGTGCGTTCCGGTGGTGGCGGACTGACTCCGTCCGATGTCGCTCCGGCGCGACTGAGTCAGTCACAGATCGACCAGCTGCACGAGCAGTATCAGATCGCCGATGTGCTGCCACTGACGCCGCTGCAGCAGGGACTGTTGTTCCACTCCAATCTGGCACCGGAAGCGATGGACGGCAGTGACGATCTGTACGCGGTGCAGCTCGATGTCGCCCTGAGCGGCCCGCTCGATCCGAAGCGGCTCCAGGAGGCCGTGCACACCGCTATCACGCGGCGCCCGAACGTTGTTGCCACCTTCTACGAGGAATTCGGCGAACCGATACAGCTCATTCCCGCTGCTCCCGAACTCGCGTGGCAATACATCGAGTTCGACGCGGACGGTGGCCTGGACGTCGAGCAACAGGTCGACCGGCTCTCCGCCGCAGAGCGGGCAGCGGTCTGCGACCTCGCCGGACAACCGGCCTTCCGGGCCGCACTGGCCCGAACCGGGGAGGACCAGTACCGGTTTGTGCTGACCAATCACCACATCGTGCTCGATGGGTGGTCCAAGCCGATCCTGCTGCAAGAGATCTTCGCCAGTTACTTCGGCGAGCGGCTTCCGGCGCCGGTGTCGTACCGCCGGTTCGTCACCTGGCTGGCCGCACAAGACAACAGCAGCGCGCGGTCGGCCTGGCGTGACGTGTTCGAAGGTTTCGAGACCCCGACACTTGTCGGTCCGCCCGGCCGAATAGTGCTGGGTCGGCGTGGGGTGGAGTCCTTCGAGGTGTCCGCCGAGACCACGCAGGCACTCGGTGAGCTCGCACGCTCCTGCCGCACCACGGTCAGTACGGTGTTGCAGGCCGCATGGGCTCAGCTGCTGATGTGGCTCACGGGCCAAAACGATGTCGCGTTCGGTACTGCGGTGTCCGGCAGGCCCAGCGACCTCGTCGGCGCCGAATCGATGGTCGGATTGTTGATCAACACCGTGCCGGTCCGCGCGACCATCACGCCGACCACCACCATCGCCGACCTGTTGAACCAACTGCAGGGCGCCTACGGAGACACGCTGGAACATCAGCATCTGGCGCTCAACGAGATTCACCATGCCGTCGGACACGATCAGCTGTTCGACACCATGTTCGTTTACGAGAACTACCCGATCGACACGGCTGCACTATCGCGTGTGCACGAGTTGTCCATCACCGGGTTCAGTAATCGTGAGTACAACCACTACCCGCTCGCGGTGCAAGCCACACCGGGCCACGAGCTGGGACTCCGCGTCGAATTTGACACTGACGTCTTCAACGCCGTCCGAATTGGAAAGTTGGTCAAGAGGTTCCAGCGTGTGCTGGAGGCCATGACATCCGATGTCAAAGGGAACAAGAAGGAGCCCGCATGA	MPLTDQLLKFALIRTADDQYYMFGLCHHINLDGLGMAIVSRRIASIYSALVAGDPVPDAYFGTLQDLVDLEAEYEASTDYTEDREYWSRNLPPDSGLDPRPPHAHEGHEGYTPTASVQIDDTVVGEIKDLTKALRVRRYSVITAACALLVRGWSTSGSEVALDFPVSRRVRPESKTLPGMLAGVVPLVLSAPPESTVAEFCQHVDVRIRELLKHQRFPAHVLDGGEFGLRGPRQAGNRVAINFIPMRLTLDLAGVPATATYTNHGPMGHFGLFFIGASDQLLLSTSGDGLPFSKFGVPNLTERLQRLLSEMAADPDRRLSSLNSLVNDELTSLAEVGNRAVLAGPVASRVSIPELFFSQVAADPEAPALTFGERTLTYRELDEAANALSGQLVSQGVGPGDRVVLLSDRSAQAVIGILAVLKAGAAYLPIDPAVPASRLEFIVGDAAPAAAITTAGLRARLDGFDLPIIDLDASAAGTEPTAPASGARPDDIAYIIYTSGTTGAPKGVAVTHHNVTQLMSSLDAGLPNPGVWPLCHSLAFDVSVWEIWGPLLRGGRLVVVPESITGSPAEFHDVLVAEQVTVLTQTPSAVAMLSPEGLESTALAVVGEACPASVVERWAPGRVMINAYGPTETTMCVAISAPLVAGAPDSAVPIGAPVPGAALFVLDTWMQPVPAGVVGELYVAGEGVACGYIGRSDLTASRFVACPFGQPGTRMYRTGDLVSWGDDGQLQYLGRADEQVKIRGYRIELGEVQAALSALDGVDHAAAIVREDRPGDKRLVGYVTGTVDPAEVRSTLAKRLPPYMVPAAVVVLEALPLTSNNKLDTRALPTPEYGGLGADYRAPGTAVEEILVGVYAQVLGVDRVGVDDSFFDLGGDSILSMQVVARARAAGVLCRPRDVFIEQTVSRLAAVVEISGGEADVVDEGLGPVEVTPIMHWLRGAQDSAGAIDEFNQTLVVQAPAAVSEDDVVVVLQALLDRHPTLRLRATDNAGEWSLLVPEVGAIDARDCLRVIDALSGETLVAARSRLNPATGAMLSAAWVPDTKQLVLVIHHLAIDGVSWRILLEDLNIAWAQHHSGADVVLPVGGTSFARWSSLLSEHARSTEVVAQADAWKEVLTAPAHVPAVQPTTDTYANAGRLSLSLDAETTRHLLGEVPAAFHAGVQDILLIAFGLAWNEFLGAGGAPIAFDIEGHGRQEEIGEAVHRRIDLSRTVGWFTTKYPASLAVGELSWAQVTAGESALSHVIKAAKEQLRALPDGLTYGLLRYLNTDIGLDGSEPTIGFNYLGRLGAGAAELSEDFWRIDHESLSLTDVAAAISMPLAHSVELNAGIVETNSDAESGPELRANWTWAPSALDDAQAARLSRLWFEALSGICAHVRSGGGGLTPSDLAPARLTQQQIDALVQQYEVTDVLPLTPLQQGLLFQAGFAEATGDSAEDDVYSVQLGLTVTGPLNASRLRDAVYAVVKRHPNLAARFSEEYGEPVQIIPAEPVIAWQHAELVGDVDQQVEQLCAAERAAVCQIFTEPVFRATLISGLGGPAESRHRLVLTAHHIVIDGWSLPILLQEIFGAYYGQRLPSPAPYRNFVTWLAAQDRVAAQRAWGVALDGFETPTLVGSLASSGRRGSESYRLSEQISRALSELARAQRTTVNTVLQAAWAQVLTWLTGQHDVAFGTAVSGRPSDLVGAESMVGLLINTVPVRANINAATTVADLLDQLQRAHNDTVEHEHLALNEIHHAVGLDRLFDTLFVYENYPIDVGAQLGVQELAITDFSSREYNHYPLSVVAMPGHELGLRVEFDTDVFELAAIEIIVDRFRQVLTAMIADPATRLSSIDLLDAGEHDRLDTWGNRAVLTRPELALTSIPELFAAQVMRAPEAIAITCGERSWSYGELDATANRLANHLVSRGAGPGERVALLLPRTGEAIAAILAVLKTGAAYLPIDPAHPDSRVEFVLGDAAPIAAVTTADLLPRLGASGIPAVDINDPAVDRQSDVALPVPAVDDIAYIIYTSGTTGAPKGVAVTHRNVAQLLESLDAELDLGQVWTQCHSLAFDYSVWEIWGALLYGGRLLIVPDAVVRSPEDLHAMLVSEQVSVLSQTPSAFYALQTADAMQPEVGQQLKLQTVVFGGEALEPQRLSPWFDSHPGLPRMINMYGITETTVHASFREIGSGDVDSTSSPIGVPLEHLAFFVLDGWLRQVPVGVVGELYVAGSGQASGYLGRSDLTTTRFVACPFGAPGSRMYRTGDLVQWGEDGQLRYVGRADKQVKIRGYRIELGEVHAALARVEGVDQAAVIAREDRPGDKRLVGYITESTKGTLDPAAVRAVLAERLPAYMVPAAVVVLGAMPLTVNGKLDTRALPAPEYQDADHYRAPEDAVEEILAGIYAQVLGVEQIGVDDSFFDLGGDSISSMQVVARARAAGLLLRPRDIFVEQTVSRLAQVAVFADGETAVVDAGTGPVVATPIIRWLHGLGGKVDEFNQTVVLQAPEGVADDDVVTVLQALLDRHATLRLRAEDSDGEWSLLVPETGTVDARECLLAVDVLTDEALRQARSRLNPASGSMLSALWERGSSRLVLIVHHLAVDAVSWRILLEDLNIGWAQHHGGQPVELPPGGTSFARWATLLDQHARAADVVALADAWRQVEAIPAALPAAHPTMDTYASAGQLSVSLDADLTRELLGEVPAAYHAGVQDILLIAFALAWNEFLGSNGAPIGIDVEGHGRQEEFAGDADLSRTVGWFTSKYPVSLAVGELSWAHVVAGNSALAPIIKDAKEQLRALPDGLTYGLLRYLNPDAGVGGPDPAIGFNYLGRLGAGGADLSEDLWRIDPDGVSITAAATSVPTPLGHTVELNAGVMEGAGPDSGRLHATWTWALSALSHDQVDRISRLWFDALAGICSHVRSGGGGLTPSDVAPARLSQSQIDQLHEQYQIADVLPLTPLQQGLLFHSNLAPEAMDGSDDLYAVQLDVALSGPLDPKRLQEAVHTAITRRPNVVATFYEEFGEPIQLIPAAPELAWQYIEFDADGGLDVEQQVDRLSAAERAAVCDLAGQPAFRAALARTGEDQYRFVLTNHHIVLDGWSKPILLQEIFASYFGERLPAPVSYRRFVTWLAAQDNSSARSAWRDVFEGFETPTLVGPPGRIVLGRRGVESFEVSAETTQALGELARSCRTTVSTVLQAAWAQLLMWLTGQNDVAFGTAVSGRPSDLVGAESMVGLLINTVPVRATITPTTTIADLLNQLQGAYGDTLEHQHLALNEIHHAVGHDQLFDTMFVYENYPIDTAALSRVHELSITGFSNREYNHYPLAVQATPGHELGLRVEFDTDVFNAVRIGKLVKRFQRVLEAMTSDVKGNKKEPA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	601.98	gnl|BL_ORD_ID|4935|hsp_num:0	5928			117	1629	colistin A; colistin B
BGC0000363.1|Glycopeptidolipid_18 # 30374 # 38104 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0000363.1|Glycopeptidolipid_18 	30374	38104	+	Loose	1000	159.458	almE	27.88	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCGCCGATCCCACCCGGACTTTGTTGTCGATGGATCTTCTCGACGACGACGATCACGACCGACTCGACGAATGGGGTAACCGCGCGGTGCTCACCGAGCCCACCGCCGAACCCGTCGCGATCCCGGTGCTGTTCGCTGTCCAGGTGGAGCGCGCGCCGGAGACCGTCGCGCTGGTGTGCGGGGACAGGTCCTGGACCTATCGCGATCTGGATCAGGTCACCAACCGCATTGCCCATCTGTTGGCGGGCAATGGAGCCGGCCCGGGAGAGGTTGTGGGGCTACTGGTTCCGCGCTCGGGCGAGGCGATCATCGGGCTGTTGGCGGTGCTGAAGACGGGTGCTGCCTATCTGCCCATCGACCCTGCCCATCCCGACGAGCGCATCAAGTTCATGGTGTCGGATGCCGAACCGGTTGCGGTTCTCACCACGGCCGACTTGAACTCGCGATTCGATGGACTCGATGTACGGGTCACTGAGATCGACGATCCCTTGATCGACGGTCAGCCGAGTTCCGCGCTCCCCGCCCCGGAGCCCGATGACCTCGCGTACATGACCTATACCTCGGGCACGACTGGGGTTCCCAAAGCGGTTGCGGTCACCCACCACAACGTCACCCAGTTGGTAGACGCGGTGCGCGCCGATCTACCGGCCGGACCCGGCCAGGTGTGGTCGCAATGGCATTCATTGGTCTTCGACGTTTCGGTGTGGGAGATCTGGGGTGCGCTACTGCACGGCGGCCGCCTGGTGGTAGTCCCGGAATCGATCGCGTCCTCACCGGATGAGCTGCACGAGCTGTTGATCAGCGAGAAGGTCAGCGTCCTGTGCCAGACACCTTCGGCCGCAGGGATGTTGTCGCCTGAGCGGTTGGAGTCGACGACGCTCATCGTCGCCGGTGAAGCCTGCCCGACCGAACTGGTGGATCGATGGGCCACCAGCGGACGAACGATGATCAACGCCTATGGCCCGACCGAGGCCACGATCTACGCGGCGATGAGTGGACCGCTGAGGCCGGGTTCGGATGTGGCACCGATCGGTTCGCCGGTGCCCGGGGCGGCGCTGTTCGTGTTGGACAAGTGGCTGCGGCCCGCGCCGGAGGGGGTGGTCGGTGAACTTTACGTCGCAGGCAACGGCGTCGCGCCCGGCTACGCGCATCGCTCCGGACTGACCGCATCGCGGTTCCTCGCCTGCCCATTCGGTGGGCCGGGCTCGCGGATGTATCGCACCGGAGATTTGGTGCAGTGGGGTGAGGACGGCCAGCTGCAGTATCTGGGCCGCGCCGATGAGCAGGTGAAGATCCGCGGGTATCGCATCGAGCTTGGTGAGATTCAGGCGGCACTGGCCCGCCTGGATGGAGTCGAGCAGGCGGTGGTGATCGCCCGCGAGGACCGTCCCGGCGACAAGCGCCTTGTCGGCTACATCATGGGGAGCGCCGACCCGGTCGAGGCTCGCACCGCACTGGCCGAAAGGCTCCCGGCGTACATGGTTCCGGCCGCAGTGGTGGTGCTGGAGACGCTGCCCCTGACGGTGAACGGCAAGCTGGACAAGCGTGCTCTTCCCGCACCCGAATACCGCAGTGTCGGTACGGATTACCGTGCACCGACCGGACCTGTCGAGAAGATCTTGGCCGATATCTACGCCCAGGTTCTCGGAGTCGATCGCGTGGGCGTCGACGAGTCGTTCTTCGATCTCGGTGGCGACAGCATCCTGTCGATGCAGGTGGTGTCGCGGGCGCGGGCGGCCGGGGTGGTGTGCCGGCCCCGCGACATCTTCGTCGAACAGACCGTCAGTGGGGTAGCGGCGGTGGCCGTGCTCTCGGACGGCCAGTCCGGAGTCGTCGACGAGGGCATCGGCCCGGTGTCGGCTACGCCGATCATGCACTGGTTGCACGGCGTACAAGGTCCCACCGACCAGTTCAATCAGACGATCGTGCTGCAGGCCCCGGCCGGGGTGACCGAGGACGATGTCGTCGTCGTGCTGCAGGCGCTGCTGGACCGGCATGCCACTCTGCGGTTGCGTGCCGAGGACAGCGATGCCCCCGATACCGACGTGTGGTCGCTGACCGTCCCGGAGAAGGGGGCGGTGAACGCGCGTGATTGCCTGCGTGTCGCCGAGACCTTGTCGGATGCGGAGTTGGTGGCGGCCCGCGCGCAGCTGAATCCGGCCACGGGCGCTGAGCTGAGTGCGGTCTGGGTCCCCGAGACCCGGCAGCTGGCCCTGATGATTCACCACCTGGCCGTTGACGGTGTGTCGTGGCGAATTCTCTTGGAAGACTTGAACATCGCCTGGGCGCAGCACCATGGCGGGCAACCGGTGGAGTTGCCGACCGGCGGGACCTCGTTCGCCCGCTGGTCGTCGCTGCTCAACGAGCACGCGCATTCCGCCGAGGTGCTCGCAACGGCCGACACCTGGCGAGAGGTGACCGCGGTTCCCGCGCCATTACCTGCCGTGCTGCCCGAGCTGGACACCTACGCCACTGCCAAGACGTTGTCGGTATCGCTGGACGCGGAGACCACCCGCGAGTTGCTCAGTGAGGTCCCGGCGGCGTTTCACGCTGGGGTGCAAGACATTCTGCTGATCGCATTCGGGCTGGCGTGGAACGAATTCCTGGATTCGAATGTGGCTTCGGTCGGCATCGGCGTCGAGGGTCATGGGCGTCACGAAGAGCTGGCAGACGATGTCGATCTGTCGCGTACCGTCGGCTGGTTCACCACCAAGTACCCGGTGGCGTTGAGCGTACGGGGTCTGTCCTGGCAGGAAGTTGCCGGTGGAGCTGCCGAATTGGGGCCAATCGTCAAGGGCGCCAAGGAACAACTGCGCGCACTTCCCGATCCGTTGACCTATGGACTGCTGCGCTACCTGAACCGCGATGTGGATCTGGCCGCGCCGGAGCCGGTCATCGGGTTCAACTACCTCGGGCGCCTCGGTGCCGGGGCAGCGGATCTCGGGGACGACCTGTGGCGGATCAACGAGGACAGCTTGACCTCGACCAGCGTGGCGTCCTCGGTGTCGATGCCGCTGATGTACACGGTGGATCTCAATGCCGGAATCGTGGAGGGTGGACTCGGTGACGAATCCGGCGCGCATCTGCGGGCCGGGTGGACATGGGCGCCCTCGTCGGTCACCGAGCCTCAGGTGCAGCGGCTGAGTCAGCTGTGGTTCGAGGCACTCGCCGGAATCTGCGCGTATGTCCGCAACGGCGGCGGCGGATTGACCCCGTCCGATATCGCGCCCGCACAGTTGAGCCAACAGCAGATCGATGAGCTGCACGAGCAGCACAACATCGTTGACGTGCTCCCGCTGACACCGATCCAGCAGGGTCTGCTCTTCCACACCACGTTCGCCCGTGCGGCCGGCGTACTGGAAGACGAGGCAGCCGGAGTCGACTTCTATGCGGTACAGCTCGACATCACGGTGACCGGTCTGGTCGACCAGCTCAGGCTCCGCGACGCGGTGCACTCAGTGGTGCGCCGTCACCCCAACCTGGCGGCCCGGTTCTGCACTCAGTTCGGAGATCCGGTACAGGTGATTCTTGCGGATCCGGTCATCGCATGGCGATACCTGGACCTTCGCGGGGACGATCTGACTCCCGACGAAGAGATTCAGCGGCTCTGCGCCGCTGAGCGTGCCGCGGTCTGCGACCTTGCCGATCGACCGACGTTGCGCGCGGCGCTGATTCGCACTCAGGGGAACAAGCACCGGTTCGTGCTGACGTTCCACCACGTCGTCATCGACGGCTGGTCGTTGCCAATCCTGTTGCAGGAGATCTTCGCGAGCTACTTCGGGCATCGGCTCCCGGCGCCGTCCTCGTACCGCAATTTCGTGAGCTGGCTGGCAGAACAGGATCGTGACGCAGCACGCTCGGCGTGGGGCACGGTGCTGGAGGGCTTCGACACTCCCACGCTCGTCGCTCCGCCCGCGCCTCCGGGTGCCAGAGGCATCGAGTCCTATCGGGTGTCGGCCGAGACCACGCAGGCCCTCGCCGATCTCGCGCGGTCGCAGCACACCACGATCAGCACGGTGTTGCAGGCCGCCTGGGCACAACTACTCATGGTGGTGACCGGACAGCACGACGTCGCATTCGGTACGGCGGTTTCGGGCCGGCCCGCAGAGCTGGCCGGATCCGACTCGATCGTGGGTCTGCTCATCAACACGGTGCCGGTGCGGGCGCGCGCCACCGCGACCACCACAGTCTCAGAGCTGTTGGCGCAGTTGCAGAGTGCTCACAACGACACCATCGAGCATGAGCATCTGGCCCTCAACGAGATTCACCACATCGCGGGCCACGAGCAATTGTTCGACACCCTCTTCCTGTACGAGAGCTATCCGATCGACACCAGCGCGTTCACGGGTGTGCAGGAGTTGGCGATCACCGAGTTCGTCACGCGCGAGTACAACCACTACCCGCTGTCGGTGATGGCGTTACCCGGTCACGAGTTGGGAATTCGCGTCGAATTCGACACCGACAAGTTCGACGCGACCCAAATCGAGGCCGTATTCGAGCGGTTCGAGCGGGTGCTGACGTCGATGGTTGCCGATGCCTCGCAACGGCTCTCGTCGCTGGATGTGCTGAAGACCAGTGAGCACCAACAGCTTGACGGCTGGGGCAATCGCAAGGTGCTGGCGCGGGGGCCGGAGCCGGTGCTGTCCATCCCGGAGTCGTTCGCCGAGCAGGTCAATAGTGCCCCGGAGGCGGTGGCGCTGACGTTCGAGGGCCGCTCCACCACCTACGGCGAGCTGGACGAGGCCGCAACGAGATTGGCGAATCTGCTGGCGATCTACGGCGCCGGTCCGGGTGAGTCGGTGGCGCTCCTGATGCCCCGCTCCGACGACGCGATCGTGGCGATCCTCGCGATTCTCAAGACCGGAGCGTCCTATCTGCCGATCGATCCCTCGGTGCCGGATACGCGATTGGAGTTCATGCTGTCCGACGCCGTGCCGGTCGCGGCTGTCACGACTGCCGAGCTACGCGCACGGTTCGATGGATCCGGAGTCTCCGTCGTCCAGTTCGATGATGCCGAGGACGACCCCACCGGCGCCATTTACGGCCATACGCCTCTGCTCACCCCGGCACCCGATGACATCGCGTACACGATTTACACGTCGGGAACGACCGGTGTCCCCAAGGGTGTGGCCATCGCGCACTCCAATGTGACCCAAGCACTTAAGTTCCCGCTCACTCACATGCCCACCGGGCCCGGTGAGGTGTGGACGCAGGCCGGGTCGCTTGTCTTCGACATCACCGTGTGGGAGATCTTTGGCGCACTGCTGCACGGTGGCCGGTTGGTGATCGTTCCGGATTCGGTGGTTCGGTCCCCGGACGATTTCCGCGATCTGCTGATCCGGGAGAAGGTCACCGTCCTGTTCCAAACCCCCTCGGCGGTCGGAATGTTGTCCCCGGAGGGTCTGGACAACATGACATTGGTTGTCGCGGGCGAAGCCTGCCCCACCGAAGTGGTGGACAAGTGGGCACCCGGCCGGGTGATGATCAACGGCTACGGCCCGACCGAGACCACCATCTATGCCACGTTCGGCGAGTTGATCGCCGGATCGGGCGTGGTGCCGATCGGTGTTCCGGTGCCCGACGCCGCGCTGTTTGTCCTGGACCGGTGGATGCGTCCGGTGCCGCCGGGTGTGGTCGGCGAATTGTATGTGGCCGGACTTGGCGTTGGTATCGGTTATGTCGGCCGCGCGGCGCTGACCGCATCGCGGTTCACGGCATGCCCGTTCGGGGAGCCAGGGGCGCGCATGTATCGCACCGGGGACCTGGTCTCGTGGGGAGACGACGGACAACTGCAGTATCTGGGCCGCGCCGATGAGCAGGTCAAGATTCGCGGTTTCCGCATCGAGCTCGGTGAGATCCAGGCCGCCCTGGCCGACCTGGACGGGGTGGAGCAGGCGGCAGTGATCGCCCGCGAGGACCGCCCCGGAGACAAGCGCCTGGTCGGGTACTTCATCGGGGCCGGCGAGCCCGCCCAACTACGCAGCTCCTTGGCCAAGCGACTGCCGCCCTACATGGTCCCGGCCGCGGTGGTACGGCTGGAGGCGTTGCCACTCACCGTCAACGGCAAGCTCGACAAGCGTGCCCTTCCGATACCTGAGTACGACGACAGGGCCCGTTACCGCGCGCCCGCCAATGCGACTGAGGAGGCGGTCGCCGGCATCTACGCCCAGGTGCTGGGTGTCGAGCGGGTGGGGACCGACGATTCGTTCTTTGATCTGGGTGGCGACTCGATCTCCGCGATGCGCGTGGTTGCCGCGATCAACACGTCGCTCGATGCGCAGCTTGCGGTGCGGACTCTGTTCGAGTCACCGTCGGTGCGCAGCCTCAGTGTGTATCTGGACGGCGCCGCAAGCTCCGGAGTCAGTGGGCCGACCTATGCATCCGTACACGGACCCGGCGCCTTGGAGGTGCGGGCCAGCGACCTCACGTTGGACAAGTTCATCGACGAGGCGACGCTGCAGGCGGCTCCGGCACTGCCCCGTGCCAACGCGCGTCCGCGGACGGTGCTGCTGACCGGGGCCACCGGTTTCCTGGGGCGCTACCTCGTGCTGCAATGGCTCAAGGAGCTGGAAGATGTTGATGGCACGCTGATTTGCCTCGTGCGTGCCAAGTCTGACGAAGATGCTCGACGTCGTCTCGACAAGACCTTCGACAGCGGAGACGCCGAACTCATCCGGGTTTACGAAGCGCTCGCCGCCGACCGTCTCCAGGTAATTGCCGGTGACAAGGCCGAGCCTGGCCTCGGTCTGGATGACGAGACCTGGCAACGGCTGTCCGGGACCGTCGACCTGATCGTCGATTCCGCGGCGCTGGTCAATAGCGTTCTGCCTTACAGCGAGTTGTTCGGACCCAACGTGGTTGGCACGGCGGAGCTGATCCGGTTCGCGTTGACCTCGAAGCTCAAGCCGTACACGTTTGTGTCGACGGCAGACGTCGGGCGCGAGATCGAGAAGTCGACCTTTGTCGAGGACGCCGATATCCGGCTCATCAGCGCCATTCGTCCTTCCGACGGGAGCTACGCCAACGGGTATGGCAACAGCAAGTGGGCGGGCGAGGTGCTGCTCCGCGAGGCCCACGAGCAGGTTGGCTTGCCGGTCACGGTGTTCCGCTCGGGCATGATCATGGTCGGCACCAGTTACGCGGGCCAGGTGAATGCCTCCGATACGGTCGCCCGAATGGTGCTGAGCGTTGTCGCCACCGGTGTTGCGCCACATTCCGTCTACCGGCTGACCGACGAAGGCGATCGTCAACGGGCGCACTTCGACGGACTTCCTGTGGAATTCGTTGCCGAGGCGATCACGACGCTGGGAGGACAGCCGGCGGGCTCGTCTACCGGAGCGGTCACCGGATTCGAGACGTATCACGTGATGAATCCACATGACGACGGCATCGGAATCGACGAGTACGTCGATTGGTTGATCGAGGCCGGCCACCCGATTGAACGCATCAGCGATTTCAGTGAATGGGTGGCGCGCTTCGAGGCCGGCCTGCACGCTTTGCCGGATCATCAACGCCAAGGCTCTGTGTTGCAGATGCTGAAAATCTTGCAGGATCACGGCTGGGATGGTCAGCCGCCGGATCCCTCGCGGGGGTCCATGGCACCGGCCGACCGATTCCAGGCCGCGGTGCGAGATGCCAAGATCGGTTCCGGTCACGACATTCCGCAAGTCTCGGCGCCAATCATCGCCAAATATGCGACCGACTTGCGATTGCATGGATTGCTTTAG	MSADPTRTLLSMDLLDDDDHDRLDEWGNRAVLTEPTAEPVAIPVLFAVQVERAPETVALVCGDRSWTYRDLDQVTNRIAHLLAGNGAGPGEVVGLLVPRSGEAIIGLLAVLKTGAAYLPIDPAHPDERIKFMVSDAEPVAVLTTADLNSRFDGLDVRVTEIDDPLIDGQPSSALPAPEPDDLAYMTYTSGTTGVPKAVAVTHHNVTQLVDAVRADLPAGPGQVWSQWHSLVFDVSVWEIWGALLHGGRLVVVPESIASSPDELHELLISEKVSVLCQTPSAAGMLSPERLESTTLIVAGEACPTELVDRWATSGRTMINAYGPTEATIYAAMSGPLRPGSDVAPIGSPVPGAALFVLDKWLRPAPEGVVGELYVAGNGVAPGYAHRSGLTASRFLACPFGGPGSRMYRTGDLVQWGEDGQLQYLGRADEQVKIRGYRIELGEIQAALARLDGVEQAVVIAREDRPGDKRLVGYIMGSADPVEARTALAERLPAYMVPAAVVVLETLPLTVNGKLDKRALPAPEYRSVGTDYRAPTGPVEKILADIYAQVLGVDRVGVDESFFDLGGDSILSMQVVSRARAAGVVCRPRDIFVEQTVSGVAAVAVLSDGQSGVVDEGIGPVSATPIMHWLHGVQGPTDQFNQTIVLQAPAGVTEDDVVVVLQALLDRHATLRLRAEDSDAPDTDVWSLTVPEKGAVNARDCLRVAETLSDAELVAARAQLNPATGAELSAVWVPETRQLALMIHHLAVDGVSWRILLEDLNIAWAQHHGGQPVELPTGGTSFARWSSLLNEHAHSAEVLATADTWREVTAVPAPLPAVLPELDTYATAKTLSVSLDAETTRELLSEVPAAFHAGVQDILLIAFGLAWNEFLDSNVASVGIGVEGHGRHEELADDVDLSRTVGWFTTKYPVALSVRGLSWQEVAGGAAELGPIVKGAKEQLRALPDPLTYGLLRYLNRDVDLAAPEPVIGFNYLGRLGAGAADLGDDLWRINEDSLTSTSVASSVSMPLMYTVDLNAGIVEGGLGDESGAHLRAGWTWAPSSVTEPQVQRLSQLWFEALAGICAYVRNGGGGLTPSDIAPAQLSQQQIDELHEQHNIVDVLPLTPIQQGLLFHTTFARAAGVLEDEAAGVDFYAVQLDITVTGLVDQLRLRDAVHSVVRRHPNLAARFCTQFGDPVQVILADPVIAWRYLDLRGDDLTPDEEIQRLCAAERAAVCDLADRPTLRAALIRTQGNKHRFVLTFHHVVIDGWSLPILLQEIFASYFGHRLPAPSSYRNFVSWLAEQDRDAARSAWGTVLEGFDTPTLVAPPAPPGARGIESYRVSAETTQALADLARSQHTTISTVLQAAWAQLLMVVTGQHDVAFGTAVSGRPAELAGSDSIVGLLINTVPVRARATATTTVSELLAQLQSAHNDTIEHEHLALNEIHHIAGHEQLFDTLFLYESYPIDTSAFTGVQELAITEFVTREYNHYPLSVMALPGHELGIRVEFDTDKFDATQIEAVFERFERVLTSMVADASQRLSSLDVLKTSEHQQLDGWGNRKVLARGPEPVLSIPESFAEQVNSAPEAVALTFEGRSTTYGELDEAATRLANLLAIYGAGPGESVALLMPRSDDAIVAILAILKTGASYLPIDPSVPDTRLEFMLSDAVPVAAVTTAELRARFDGSGVSVVQFDDAEDDPTGAIYGHTPLLTPAPDDIAYTIYTSGTTGVPKGVAIAHSNVTQALKFPLTHMPTGPGEVWTQAGSLVFDITVWEIFGALLHGGRLVIVPDSVVRSPDDFRDLLIREKVTVLFQTPSAVGMLSPEGLDNMTLVVAGEACPTEVVDKWAPGRVMINGYGPTETTIYATFGELIAGSGVVPIGVPVPDAALFVLDRWMRPVPPGVVGELYVAGLGVGIGYVGRAALTASRFTACPFGEPGARMYRTGDLVSWGDDGQLQYLGRADEQVKIRGFRIELGEIQAALADLDGVEQAAVIAREDRPGDKRLVGYFIGAGEPAQLRSSLAKRLPPYMVPAAVVRLEALPLTVNGKLDKRALPIPEYDDRARYRAPANATEEAVAGIYAQVLGVERVGTDDSFFDLGGDSISAMRVVAAINTSLDAQLAVRTLFESPSVRSLSVYLDGAASSGVSGPTYASVHGPGALEVRASDLTLDKFIDEATLQAAPALPRANARPRTVLLTGATGFLGRYLVLQWLKELEDVDGTLICLVRAKSDEDARRRLDKTFDSGDAELIRVYEALAADRLQVIAGDKAEPGLGLDDETWQRLSGTVDLIVDSAALVNSVLPYSELFGPNVVGTAELIRFALTSKLKPYTFVSTADVGREIEKSTFVEDADIRLISAIRPSDGSYANGYGNSKWAGEVLLREAHEQVGLPVTVFRSGMIMVGTSYAGQVNASDTVARMVLSVVATGVAPHSVYRLTDEGDRQRAHFDGLPVEFVAEAITTLGGQPAGSSTGAVTGFETYHVMNPHDDGIGIDEYVDWLIEAGHPIERISDFSEWVARFEAGLHALPDHQRQGSVLQMLKILQDHGWDGQPPDPSRGSMAPADRFQAAVRDAKIGSGHDIPQVSAPIIAKYATDLRLHGLL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	463.31	gnl|BL_ORD_ID|4935|hsp_num:0	5928			117	1629	colistin A; colistin B
BGC0000363.1|Glycopeptidolipid_20 # 38856 # 39074 # -1 # ID=1_20;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.580	BGC0000363.1|Glycopeptidolipid_20 	38856	39074	-	Loose	500	25.0238	PER-6	41.18	3002368	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	CTAGACGATGCCTACGCCGGTAAGTACCTGCCAGACCCCGACCACCGCGAAAAGGATGAGCAGCACCAGTTGTCGGTGGGCAAGCGCCCAATTGTGAACCGGTTCCAGAACGGCTTGAGTCCTCGCCGGAGCGATCACGTAACTGATGAGTGCCACCTCGAAAACGGCGAGCATCGCGAAGACGAAAACGATGGCAGCCAGAATCTGCGTACCCATTGA	LDDAYAGKYLPDPDHREKDEQHQLSVGKRPIVNRFQNGLSPRRSDHVTDECHLENGEHREDENDGSQNLRTH	MNVIAKGVFTTTALLMLSLSSWVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLLVNPFEKFPMQSVFKMHLAMLVLHQVDQGKLDLNKTVAVNRAAVLQNTWSPMMKDHQGDEFTVTVQQLLQYSVSHSDNVACDLLFELVGGPAALHAYIQSLGIKETEVVANEAQMHADDQVQYKNWTSMKAAAQLLRKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTVVAHKTGTSGVRAGKTAATNDIGVIMLPDGRPLLVAVFVKDSAESARTNEAIIAQVAQAAYQFELKKLSAVSPD	23.38	gnl|BL_ORD_ID|1375|hsp_num:0	1493			255	357	
